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ABSTRACT 
 
IBRAHIM DUQUM: A Comparative study on the effect of Integrin subunits Beta one and 
Beta 3 on Osteoblast Implant interactions.  
(Under the direction of Dr. Lyndon F Cooper, DDS, PHD) 
 
      Background: Integrin transmembrane receptors has emerged as central regulators of cell 
biomaterial interactions. 
     Aim: to explore the effects of integrin β1 and β3 receptors on osteoblast implant surface 
interactions in vitro. 
     Materials and methods: specific monoclonal antibodies were used to functionally 
perturb the respective integrin receptors before cell plating on CpTi disks of two distinct 
surface topographies. RT²Profiler™PCR Arrays system, quantified the expression of a panel 
of osteogenesis related genes. Moreover, scanning electron microscopy was used to evaluate 
the effects of integrin functional perturbation on initial cell adhesion and spreading, in a 
surface and time dependent manner.  
     Results: data from both morphological and molecular studies showed that functional 
perturbation of both integrin subunits, significantly affected initial cell adhesion, spreading, 
and osteogenesis related gene expression, in a surface dependent manner. 
     Conclusion: Integrin β1 and β3 are involved in initial osteoblast adhesion and spreading 
on implant surface. Moreover, they mediate implant surface specific changes. 
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CHAPTER 1 
 
 INTRODUCTION 
 
 
       The introduction of new medical techniques intended to help patients in overcoming 
their disabilities and improve their quality of life has always been a priority. However, any 
novel concept should be based on solid scientific evidence to ensure long term success with 
minimal side effects. Osseointegration is a concept that was introduced by Branemark and his 
colleagues in the mid 1960’s, and since then it has been a leading topic of interest. Based on 
this concept many new techniques and materials have evolved and are available to facilitate 
treatment and rehabilitation of patients.  
      Branemark placed his first intraoral implant in 1965. Despite having poor clinical results 
in the following 5 years with a success rate of about 50%, Osseointegration research continue 
to expand with the introduction of new surgical protocols and implant designs. Indisputable 
progress was made during the 1970’s. This resulted in significant improvement and 
scrupulous documentation in the field of implantology leading to its general acceptance in 
Europe. Another important historical event in endosseous implant evolution was their 
introduction in North America in 1982. The last three decades were marked by expanded 
Osseointegration research, and tremendous increase in endosseous implants usage (9).  
      Orthopedics, bone-anchored hearing aids, craniofacial prosthetics, and Prosthodontics are 
some of the fields that were positively impacted and rejuvenated by the use of endosseous 
implants. Tissue integrated prostheses are currently a predictable and highly reliable 
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technique. Endosseous implant markets are growing very rapidly world wide (2, 80, 81). 
Endosseous implants are used to support and retain all kinds of prostheses in Dentistry and 
Maxillo-facial prosthetics from single tooth to prosthetic ears and noses.  Moreover, they 
have a wide variety of uses in medicine particularly in the joint replacement field. The impact 
of those new treatment modalities on patient’s life as well as on treatment planning 
procedures has been tremendous. Implant supported prostheses are the standard of care 
nowadays to replace missing teeth. 
       Despite the success, many unanswered questions remain unanswered. Studying the 
molecular aspects of Osseointegration is an important mode of its research. The tissues that 
oppose endosseous implants are multidimensional and represent diverse and dynamic living 
entities. Interfacial tissues include epithelium, soft fibrous connective tissues, and calcified 
bone (113). These living tissues are regulated at the molecular level. It is important to 
consider that the clinical success of endosseous implants is associated with the formation and 
maintenance of bone at implant surfaces (77). This research project aimed to understand 
some of the fundamentals of Osseointegration, and to reveal the importance of the integrin 
receptors in the early stages of this process. Integrins are a group of transmembrane proteins 
that mediate the interaction and cross-talking of the cells with extracellular matrix 
components and other cells. These receptors particularly integrin beta1 (Itgβ1) and integrin 
beta3 (Itgβ3) are thought to play a critical role in Osteoblast interaction with implant surface. 
Nevertheless, their exact role in this process is yet to be explicitly elucidated.   
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1.1. Process of Osseointegration 
      Osseointegration was first described by a Swedish orthopedic surgeon PI Branemark. He 
discovered that commercially pure titanium (cpTi) when placed in a suitable preparation site 
in the bone could become fixed in place due to a close contact between the implant and 
surrounding healthy bone. Furthermore, he discovered that the integrated cpTi implants had 
the ability to transmit functional loads over an extended period without harmful effects either 
systemically or in the adjacent tissues. 
 
1.1.1. Definitions 
      Branemark and his colleagues defined Osseointegration as the direct functional and 
structural connection between bone and the load carrying implant (19). Another definition 
that gained popularity was introduced by Albrektsson and collaborates, they defined 
Osseointegration as the process in which clinically asymptomatic rigid fixation of alloplastic 
materials is achieved and maintained in bone during functional loading (11). These 
definitions describe the clinical observation of clinical stability of implants. They verify the 
success of Osseointegration at the anatomical and histological level. Radiographic and 
histological examinations can be used to insure the direct bone to implant contact without 
intervening fibrous connective tissue. However, these definitions do not explain the 
biological processes controlling bone formation and maintenance at the implant bone 
interface. Osseointegration is a dynamic process that involves complex cascade of cellular 
and molecular events. It results in bone formation at the bone implant interface (29). The 
maximum bone deposition is achieved by 3-4 months after implant placement. Bone 
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remodelling through constant resorption and new bone apposition is a continuous process 
that supports the long term functional integration of endosseous implants (77). 
1.1.2. Peri-implant bone healing 
      It is important to understand the cellular and molecular determinants of bone formation at 
the implant interface. These cellular and molecular activities can be targets for innovative 
strategies to improve and facilitate implant therapy (29). The process starts immediately after 
the surgical placement of the endosseous implants. This triggers the bone healing process that 
results in bone deposition around the implant. The events involved in bone healing at the 
implant interface recapitulate the events of wound healing. The process is dynamic and time 
related. After homeostasis, platelet activation, and blood clot formation, fibrinolysis occurs 
with the formation of loose connective tissue that supports the development of new blood 
vessels. This is followed by the recruitment, proliferation, and differentiation of osteoblastic 
cells. Eventually, the formation and the mineralization of a collagen matrix that surrounds the 
osteoblastic cells are completed, and woven bone is formed. The woven bone will be 
subsequently transformed to a more organized lamellar bone that is more resistant to physical 
strain. The time line of these series of events is about 4 months after implant placement. The 
formed bone is dynamic, vascular, living tissue that will continue to remodel through out life 
(29, 37). 
 
      Bone remodelling reflects the functional adaptation of the bone structure to load by 
changing the dimension and the orientation of the supporting elements (110). Remodelling 
starts with osteoclastic resorption, followed by lamellar bone deposition. Resorption and 
deposition are coupled in space and time. Bone deposition on the implant surface results 
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from two distinct mechanisms: Distance Osteogenesis and Contact Osteogenesis. These two 
mechanisms were described by Osborn and Newesley in 1980 and refer to the general 
relationship between forming bone and the surface of implanted material. Both involve the 
formation of new bone “De Novo Bone Formation” (38). 
      Distance Osteogenesis occurs when new bone is formed on the surfaces of old bone in 
the peri-implant site. The bone surface provides a population of osteogenic cells that lay 
down a new matrix that encroaches on the implant. The new bone will not form directly on 
the implant but on the old bone around the implant until the implant is surrounded by bone. 
In these circumstances, the implant surface will always be partially obscured from bone by 
intervening cells. Micro damage that occurs during implant site preparation will stimulate 
new bone formation. Bone necrosis usually occurs adjacent to osseous wound site despite 
optimal surgical technique. Distance Osteogenesis can be viewed as a reparative reaction to 
repair this necrotic bone. Thus this mechanism is expected to occur more in cortical bone 
healing as the bone is more compact (94). 
     Contact Osteogenesis occurs when bone is formed directly at the surface of the implant. It 
relies on the migration of differentiating osteogenic cells. These osteogenic cells are thought 
to be derived from undifferentiated perivascular connective tissue cells. They migrate 
through the fibrin matrix and the other structural proteins in the blood clot to the implant 
surface. The implant surface will be colonized and populated by cells that will differentiate 
and initiate bone matrix formation and bone deposition (38). Another term that is used to 
describe this process is Osteoconduction that is represented in Figure 1.1. 
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Figure 1.1: Osteoconduction: The dark blue area represents the implant and its surface. The 
black lines represent the fibrin that is adherent to the implant surface before cell migration. 
The red cells represent the red blood cells. The light blue objects represent the platelets. And 
the green cells represent the migrating differentiation osteogenic cells that will ultimately 
differentiate into osteoblasts. The osteoblasts will populate the implant surface and starts the 
formation of bone matrix and bone deposition. 
 
     Osteoconduction relies on the migration of differentiating osteogenic cells, connective 
tissue cells, blood cells, and platelets to the implant surface. Clearly, the implant design in 
general and surface in particular has a profound influence on Osteoconduction. It maintains 
the anchorage of the scaffold that the cells use to reach and populate the implant surface. We 
can assume that rough implant surface will promote Osteoconduction by both increasing the 
available surface area for fibrin attachment and by providing surface features with which 
fibrin could become entangled (38). The metabolic activity of the osteogenic cells is 
dependent upon an adequate blood supply. Distance and Contact osteogenesis together result 
in juxtaposition of bone to the implant surface. While they occur concurrently at all implant 
sites, a favorable result is more likely to be achieved with implant that optimizes contact 
osteogenesis, hence providing early stability of the implant. 
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      Another important process associated with bone formation at implant surfaces is 
Osteoinduction. It involves the recruitment of mesenchymal stem cells to become 
osteoblasts. In addition to the differentiated bone cells, like Osteoblasts, Osteoclasts, and 
Osteocytes, bone and adjacent tissues contain a number of less differentiated cells. These 
undifferentiated cells are important for proper bone healing and anchorage of an implant. 
These cells can be recruited to form osteoprogenitor cells, and with time they will develop 
into differentiated bone cells with the correct inductive signal or stimulus (7). Several 
cytokines and growth factors work as inductive signals for osteoblast recruitment and 
differentiation. The undifferentiated mesenchymal cells can be transformed into a 
preosteoblast, a process which constitutes bone induction (figure 1.2). This process will 
result in alteration in cell number. Increasing bone formation at the implant surface in an 
osseous wound requires increased numbers of cells or enhanced biochemical activity (29). 
Osteoinduction is a basic biological mechanism that occurs regularly as an example in 
fracture healing and implant incorporation. The injury releases local, biochemical and 
biophysical messengers that guide the cells to respond in the proper manner. However, these 
molecular strategies can be a target to enhance osteoblastic proliferation and differentiation 
in an attempt to improve bone formation at implant surfaces. 
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Figure 1.2: Osteoinduction: Adequate number of bone forming cells is needed for proper 
bone healing and repair. Undifferentiated cells are induced to become preosteoblasts that will 
from the majority of the newly formed bone.  
 
     Osteoinduction and Osteoconduction are combined in space and time around endosseous 
implants and result in new bone formation. This process starts by the deposition of a collagen 
rich bone matrix. This matrix is deposited by the committed mesenchymal cells in the 
implant vicinity. It contains large amount of type I and type III collagen, growth factors, and 
other mediators. It serves as a space filling scaffold for cell migration and osteoblastic 
differentiation. Simultaneously, endosteal bone formation is activated by committed 
osteoblastic cells differentiation into secretory osteoblast. This contributes to new bone 
formation by depositing a complex extracellular matrix that has the potential to support 
calcium phosphate deposition and matrix mineralization (59, 103). This will eventually result 
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in the formation of mature mineralized bone around the endosseous implant. Nevertheless, a 
20-50 nm electron dense zone was found to separate the implant from the mineralized bone 
matrix (112).       
 
1.2. Factors affecting Osseointegration 
      Several local and systemic factors can affect and assure the process of osseointegration. 
Albrektsson and his colleagues proposed six factors that affect osseointegration (6). These 
factors are presented in table 1.1. 
  
  Table 1.1.  Factors affecting Osseointegration  
1. Implant material 
2. Implant design 
3. Surface quality 
4. Surgical techniques 
5. Status of the bone 
6. Implant loading conditions 
 
  
     However, other investigators classified these factors into three groups as following: 
A. Clinician related factors: this includes the surgical techniques involved in the implant 
placement, loading protocols as well as implant stability. 
B. Patient related factors; this includes all the systemic and local factors related to the 
patient health such as any systemic disease or habits that have an impact on 
osseointegration or the surgical outcome. Examples include Diabetes mellitus, 
radiation, and smoking. Furthermore, any local condition that affect osseointegration 
including bone quality and quantity and local anatomical factors. 
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C. Implant related factors: These factors include all aspects related to implant design 
such as implant length, width, and shape. Furthermore they also include implant 
materials, biocompatibility, and surface characteristic and composition. These factors 
were and continue being an important area of innovative research and technology to 
improve and enhance the out come of implant therapy.    
      Detailed discussions of all the factors that affect osseointegration are beyond the 
scope of this thesis. However, some of the important factors related to this project will be 
discussed in details such as, implant materials, biocompatibility, and surfaces. 
1.2.1. Dental implant materials and biocompatibility 
      Multiple biomaterials have been used to fabricate dental implants. These materials can be 
categorized into two different ways. First they can be classified according to their chemistry 
into (1) Metals. (2) Ceramics. (3) Polymers. These materials can also be classified according 
to the biological response they elicit when implanted and their long term interaction with the 
host tissue. From the biological response point of view, implant materials can be classified 
into (1) Biotolerant. (2) Bioinert. (3) Bioactive. Table 1.2 summarizes all the dental implant 
materials and their classification from both chemical and biodynamic point of views, 
according to classification proposed by Sykaras and collaborates (119). 
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Table 1.2: Classification of dental implant materials  
 
Chemical composition Biodynamic 
activity 
Metals Ceramics Polymers 
Biotolerant -Gold 
-Cobalt-chromium 
alloys 
-Stainless steel 
-Zirconium 
-Niobium 
-Tantalum 
 -Polyethylene 
-Polyamide 
-Polymethylmethacrylate 
-Polytetrafluoroethylene 
-Polyurethane 
Bioinert - Commercially 
pure titanium 
 
-Titanium alloy 
-Aluminum oxide 
-Zirconium oxide 
 
Bioactive  -Hydroxyapatite 
-Tricalcium phosphate 
-Tetracalcium phosphate 
-Calcium pyrophosphate 
-Fluoroapatite 
-Brushite 
-Carbon: vitreous Pyrolytic 
-Carbon-silicon 
-Bioglass 
 
 
     A biocompatible material is defined as the material that has the capability to exist in 
harmony with the surrounding biological environment (1).   The different levels of 
biocompatibility emphasize the fact that no material is completely accepted by the biologic 
environment.  To optimize biologic performance, artificial structures should be selected to 
minimize the negative biologic responses while ensuring adequate function. Biotolerant 
materials are those that are not necessarily rejected when implanted into the living tissue, but 
are surrounded by a fibrous layer in the form of a capsule. Bioinert materials allow close 
apposition of bone on their surface (Contact osteogenesis). Bioactive materials allow bone 
formation on their surface, but ion exchange with the host tissue leads to the formation of a 
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chemical bond along the interface (bonding osteogenesis). Both the bioinert and the bioactive 
materials are also called osteoconductive materials as they act as a scaffold allowing bone 
growth on their surfaces. Biotolerant, bioinert, and bioactive materials are all biocompatible 
by definition and result in a predictable host response in specific applications (93). 
     Commercially pure titanium cpTi (99.75%) is the most commonly used material for 
endosseous implants. This material has various degrees of purity (graded 1 to 4). This purity 
is characterized by oxygen, carbon and iron content. Currently most dental implants are made 
from grade 4 cpTi, as it is stronger than other grades (115). Commercially pure titanium has a 
high corrosion resistance and good biocompatibility. This is attributed to the oxide surface 
layer (titanium oxide) that forms upon contact with air or tissue fluids (60). Moreover, this 
oxide layer is rapidly formed with a controlled thickness and has the ability to repair it self 
instantaneously. The aforementioned features contribute to this material high passivity, 
making it the material of choice for endosseous implants fabrication. Other important 
characteristics of this material are its high mechanical strength and low density with a 
modulus of elasticity that is compatible with bone (119).  However, it has low shear strength 
and wear resistance that renders it unsuitable for the use on articulating surfaces. 
      Titanium alloy (Ti6AL4V) is another material that is commonly used to fabricate 
endosseous implants. Titanium is combined with Vanadium and Aluminum to form the alloy. 
The main purpose is to increase the strength, improve fatigue properties, and to decrease 
weight of the fixture. Although the general perception was that cpTi and the titanium alloy 
will perform similarly. Some studies showed that the development of the bony interface is 
retarded with the alloy compared to the cpTi. Johansson and his colleagues performed a 
quantitative comparative study in rabbits. They measured the removal torque force needed to 
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loosen an implant from bone and used microscopic quantification of the amount of bone to 
implant contact. Although there was no difference after one month, the 6 and 12 month data 
showed that cpTi implants were more stable with a higher percentage of bone to implant 
contact in the cpTi group (58). 
     Other materials used to fabricate endosseous implants are ceramics. These materials can 
be bioinert or bioactive. The initial motive for the introduction of ceramics in implant 
dentistry was based upon the relative biological inertness they exhibit in comparison to 
metals. More emphasis has been given to bioactive and bioresorbable ceramics, materials that 
show signs of binding with bone and replaced by normal tissue over time. Hydroxyapatite 
(HA), tricalcium phosphate, and bioglasses are the more commonly used bioactive materials. 
They can make up the entire implant or applied in the form of coating onto the metallic core. 
Hydroxyapatite is a calcium phosphate material that has an apatite crystal. It is commonly 
used as coating to the implants. Being highly bioactive and osteoconductive, calcium 
phosphate coated implants demonstrated earlier and greater bone bonding at least in the 
initial stages (14, 22). Some investigators suggested that HA-coated implants may be 
valuable treatment modalities when placing implants (1) in type IV bone, (2) in fresh 
extraction sites, (3) in grafted maxillary and/or nasal sinuses, or (4) when using shorter 
implants (less than or equal to 10 mm)(16). Caulier and coworkers found improved 
performance with threaded calcium phosphate coated implants placed in less mineralized 
trabecular bone in goats although, the thickness of the coating decreased overtime(25).  Hahn 
and Vassos showed success of 97.8% at 6 years with HA-coated cylindrical implants after 
prosthodontic rehabilitation. Their initial data showed a surgical success of 96.4% before 
prosthetic treatment (52).  With all these promising observations there was still some 
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concerns and controversy regarding the use of calcium phosphate coated implants. Some of 
these concerns were reviewed by Biesbrock and Edgerton; they include microbial adhesion, 
osseous breakdown, and coating failure (16). Albrektsson evaluated the published in vitro 
and short and long term in vivo evidence on HA-coated implants and came out with the 
following concluding remarks. 
1. The long term experimental evidence was very negative. 
2. The early positive findings of higher bone to implant contact compared to titanium 
control either equalized or changed to a lower response with increasing time. (50%-75% 
more bone around the titanium control after 6 months or more) 
3. These findings were not dependant on implant design (5). 
     From the previous discussion we can conclude that commercially pure titanium is the 
material of choice for the fabrication of endosseous implants. It has adequate physical and 
chemical properties, and provide long term efficacy. 
 
1.2.2. Implant surface characteristics and its role in Osseointegration 
     Implant surface characteristics play a crucial role in the short and long term success of 
endosseous implants (6). The literature shows that the rate and the quality of 
Osseointegration in titanium implants are related to their surface properties (68). Two 
categories of surface characteristics are cited as being important in tissue response to 
endosseous implants. One category includes the topographic and morphological 
characteristics that are referred to as surface roughness in many instances. The other category 
includes the chemical properties which include the chemical composition, charge, and 
hydrophilicity of the surface. It is hard to practically separate these two different categories, 
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because methods used to alter surface morphology frequently lead to changes in surface 
chemistry (91). Massaro and collaborates examined the surfaces of five commercially 
available titanium implants which are fabricated from cpTi using scanning electron 
microscopy and X-ray photoelectron spectroscopy. They found out that some surfaces have a 
variety of elements and chemical compounds not related to the metal composition that might 
affect the physico-chemical properties of the surface (76). The purpose of surface 
modification is to retain the key bulk properties of the material while modifying the surface 
to improve biocompatibility. Typically, this is done by altering the atoms or molecules on the 
existing surface chemically or physically, or by coating the existing surface with a different 
material. 
1.2.2.1. Chemical composition of the surface of endosseous implants 
      Commercially pure titanium and titanium alloy as mentioned earlier are the two most 
commonly used materials for endosseous implants. These materials dominate because of the 
combination of mechanical properties and biocompatibility. The biocompatibility is related 
to the formation of the stable oxide layer, primarily titanium oxide (TiO2) that spontaneously 
forms when titanium is exposed to oxygen. Depending on the method of preparation and 
sterilization cpTi implants can have an oxide thickness of 5-6 nm (76). This oxide layer will 
determine the chemical properties of the implant rather than the implant material (60). The 
biomaterial surface interacts with water, ions, and numerous bio-molecules after 
implantation. The nature of these interactions, such as hydroxylation of the oxide surface by 
dissociative absorption of water, protein adsorption and denaturation, determine how cells 
and tissue respond to the implant (91). The composition and charges of the implant surface 
are critical for protein adsorption and cell attachment. Moreover, the surface chemical 
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composition also affects the hydrophilicity of the surface. Highly hydrophilic surfaces seem 
to be more favorable for interactions with cells, tissues, and biological fluids. A recent 
animal study found out that a more hydrophilic surface gave a higher bone to implant contact 
(21). Another important aspect of surface chemistry is the ability to manufacture a bioactive 
surface with chemical modifications of cpTi. These surfaces have the ability to show 
chemical bonding in addition to biomechanical anchorage (10). Calcium phosphate coated 
implants have the aforementioned features. However, as discussed in the previous section 
they have some potential problems that limit their clinical use. Other surfaces that have a 
bioactive potential include fluoridated OsseoSpeed implant surface by Astra Tech and the 
NanoTite surface by BIOMET 3i. Several in vitro and in vivo studies showed improved 
performance of these surfaces compared to controls (33, 43, 49, 88).  
1.2.2.2. Surface topography of endosseous implants 
     Topographic and morphologic configuration of implant surface is another surface feature 
linked to implant behavior. The surface topography describes the degree of roughness the 
surface exhibits, and the orientation of the irregularities of the surface. Several advantages 
have been attributed to increased surface roughness: increased surface area of the implant 
adjacent to bone, improved cell attachment to the implant surface, increased bone presence at 
the implant surface, and increased biomechanical interaction of the implant with the bone. A 
potential disadvantage of rough surface is inflammation of the peri-implant mucosa if the 
rough surface is located at the trans-mucosal area (peri-implantitis). Nonetheless, there is no 
solid clinical evidence to support this (28).  A recent meta-analysis by the Cochrane 
collaboration has not found any clinical evidence demonstrating the superiority of any 
particular implant surface or system. Moreover, it didn’t identify any significant correlation 
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between surface roughness and periimplantitis (44).On the other hand, there are multiple 
other reviews that showed a paramount evidence of improved performance of rough surfaces 
both from in vitro and in vivo investigations(27, 28, 106). Surfaces are simply described as 
rough or smooth. This categorization is intended to segregate machined surfaces from others. 
This dichotomous categorization is not sufficient, it misrepresents the fact that machined 
surfaces are not smooth or polished and that rough surfaces can vary considerably in their 
features (28, 91). Several guide lines were proposed by Wennerberg and Albrektsson for the 
evaluation of surface topographies (123). Detailed descriptions of these parameters are 
beyond the scope of this discussion. However, surface roughness can simply be divided into 
different levels depending on the scale of the features. Table 1.3 summarizes the different 
roughness scale levels of endosseous implant surfaces with their advantages and potential 
risks (10, 68). 
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Table 1.3: Characteristics of different implant surface scale levels 
Roughness 
scale 
Roughness (Sa) Advantages Potential risks 
and problems 
Clinical usage 
and examples 
Macro-Rough Millimeters to 
tens of microns 
Mechanical 
interlocking 
between implant 
surface and bone 
ingrowth 
Periimplantitis, 
ionic leakage 
Threaded screws 
and 
macroporous 
surface 
treatment 
Rough > 2.0 μm Improved bone to 
implant contact 
over turned 
implants. But 
weaker response 
than moderately 
rough implants 
Periimplantitis Plasma sprayed 
and HA-Coated 
implants 
Micro-Rough 
(Minimally and 
moderately 
rough) 
0.5-2 μm Improved bone 
response with 
good clinical 
documentation 
 Most implants 
used today ( 
SLA, Tioblast, 
TiUnite…etc) 
Nano-Rough 
(nano-scale) 
Nanometers to 
millimeters 
Protein adsorption 
and adhesion of 
osteoblastic cells 
Reproducible 
surface roughness 
is difficult 
Nanosclae 
implants 
(NanoTite, 
Osseospeed ) 
Machined 
(turned) 
0.5-1 μm Longest clinical 
documentation  
Longer time for 
integration and 
higher failure rate 
in low bone 
quality 
Turned implants 
mostly before 
1995, Osseotite 
 
     By careful interpretation of the information provided in table 1.3 we can conclude that 
moderately rough surfaces with mircrotopographic features have some clinical advantages 
compared to smoother turned and rougher plasma-sprayed surfaces(10). Moreover, nano-
rough surfaces seem to positively impact Osseointegration and look very promising. 
Although the clinical advantage of micro-rough surface is evident, the exact mechanisms 
behind its role in Osseointegration are still not clear especially at the cellular and molecular 
levels. Multiple theories were proposed to explain the enhanced performance of 
mircrotopographic surfaces on how they increase the rate or early Osseointegration. Some 
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investigators highlighted the ability of micro- textured surfaces in promoting early bone 
healing and their effectiveness in retaining fibrin during the critical osteogenic cell migration 
stage of Osteoconduction (38). Another important effect of the micro-textured surfaces on 
the early events of endosseous bone healing was attributed to its ability to promote blood clot 
retention. These observations emphasize the importance of implant surface microtopography 
in orchestrating the biological cascades of early peri-implant endosseous healing (38). The 
effect of implant surface on cellular attachment and osteoblastic proliferation and 
differentiation is another step in the early events that orchestrate peri implant healing. There 
is growing evidence to support the use of micron-scale cp titanium implant surfaces. Several 
studies showed that micro- rough surfaces produce the topography and the morphology that 
is favored by the cells to enhance cell adhesion, osteoblastic differentiation, and matrix 
mineralization (65, 75, 100, 101). Nevertheless, the exact mechanisms and pathways that 
govern cells interaction with surfaces of different topographies remain unknown.  
1.3. Models of Osseointegration research 
      The initial concept of Osseointegration stemmed from vital microscopic studies of the 
bone and marrow response to blood flow through titanium chambers (18). These microscopic 
in vivo studies that were performed by Branemark and his collaborates in the early 1960s are 
considered the standard by which all other clinical implant research is compared (111). 
Following the development of this concept, new basic and clinical research efforts have 
emerged to reexamine this paradigm. Osseointegration research developed very rapidly 
during the last 3 decades to cover all clinical and scientific aspects of this phenomenon. 
Different research models were used in the endosseous implant research. These models can 
be simply classified into two categories; in vivo and in vitro models. 
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1. In vivo models: these models include randomized human clinical trials as well as 
prospective and retrospective human cohort studies. Implant survival and success 
rates, patient satisfaction, complications, tissue response, loading protocols are some 
of the aspects that can be evaluated in such studies. Another integral part of the in vivo 
models includes the animal studies. This in vivo module is an essential step in the 
testing of endosseous implants prior to their clinical use in humans. Any new implant 
material or surface has to be tested in animal to ensure its biocompatibility, 
mechanical stability and safety (89). A clear advantage of the in vivo models, is the 
ability to mechanically tests and evaluate the osseointegration process. A number of 
biomechanically applied tests were utilized to compare and contrast the strength and 
integrity of the bone to implant contact on different implant materials, designs, 
surfaces. The pull or push out test and removal torque test are examples of those in 
vivo models of osseointegration (77). In vivo animal studies are also beneficial in the 
evaluation of the bone tissue interface, particularly at the microscopic level and the 
molecular levels. These will provide important information to answer some of the 
fundamental question about Osseointegration, and extrapolate results from in vitro 
studies to the in vivo situation (87). 
2. In Vitro Models: in vitro tests cover a wide range of endosseous implant research.  
Biomaterial testing, biomechanical tests as well as cell culture model are examples of 
in vitro models of Osseointegration research. An important aim of in vitro models of 
biomaterial research is to investigate biological responses to biomaterials. And 
materials used for implantology are no exception. There are two broad categories of 
use for in vitro systems in investigating cell responses to biomaterials:  
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(1) fundamental studies on the mechanisms of cell response, and (2) modeling physiological 
function in vivo (20). The value of using cell cultures to model physiological function in vivo 
is controversial. Cells must surely experience different environments in vitro and in vivo, 
which open critics that they may well be irrelevant to cell responses in vivo. Nevertheless, 
cell culture models offer unique opportunities to investigate biological responses to 
biomaterials.  They provide a useful tool for investigating cell and matrix interaction with 
alloplastic materials and their surfaces. Processes, such as cell attachment, motility, 
proliferation, differentiation, and protein synthesis can be investigated (31, 30). Culture 
models have the advantage of allowing more controlled conditions especially at the cellular 
level and help reducing animal experiments. The osteoblast cell culture model is the most 
widely used cell culture mode in osseointegration research. This model proved to be very 
successful in investigating the aspects of bone formation and osteoblast implant interactions. 
Different osteoblastic cell lines with different state of phenotypic maturation have been 
utilized to study osteoblastic response to different implant material and surfaces (31, 17). The 
following section will review the characteristics of the osteoblast, its functions, and the 
various cell lines and culture systems available, with particular emphasis on the osteoblast-
like mouse non-transformed MC3T3-E1 cell line. 
 
 
1.4. The Osteoblast 
     Bone is a mineralized tissue that confers multiple mechanical and metabolic functions to 
the skeleton. Bone is composed by cells and an extracellular matrix which becomes 
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mineralized by the deposition of calcium hydroxyapatite, giving the bone rigidity and 
strength. Bone has three distinct cell types: the osteoblasts, or bone-forming cells, the 
osteoclasts, or bone-resorbing cells, whose functions are intimately linked, and the 
osteocytes, which are osteoblasts entrapped within lacunae. In order to balance bone 
formation and resorption in healthy individuals, osteoblasts secrete factors that regulate the 
differentiation of osteoclasts and osteocytes secrete factors regulating the activity of both 
osteoblasts and osteoclasts. Bone is constantly being resorbed by osteoclasts and then 
replaced by osteoblasts in a process called bone remodelling, which is tightly synchronized 
by local and endocrine factors (42). It is apparent that any imbalance in this process will lead 
to problems. In endosseous implant therapy the clinical success is related to the formation 
and maintenance of bone at the bone implant interface (77). The formation of bone at the 
implant surface is associated with the osteoblast metabolic and secretory activities (39). 
Nevertheless, the maintenance of bone at the interface is related to the long term balance 
between bone resorption and reformation. 
      Osteoblasts are mononuclear, not terminally differentiated, specialized cells that form 
bone. They arise from osteoprogenitor cells of mesenchymal origin and terminally 
differentiate to osteocytes. These cells have a set of distinctive characteristics that include the 
capability of forming a collagen rich matrix (osteoid) and mineralizing it, which results in the 
formation of calcified bone. When they are active they have a large Golgi apparatus and an 
abundant rough endoplasmic reticulum. In addition, they form tight junctions with adjacent 
osteoblasts and have regions of plasma membrane specialized in vesicular trafficking and 
secretion (23). Moreover, osteoblasts are autocrine regulatory cells that synthesize and 
deposit growth factors into the bone matrix and respond to these factors when they are 
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released during bone resorption phases of repair and remodelling. Moreover, osteoblast 
commitment, differentiation, and function are governed by several transcription factors, 
resulting in expression of phenotypic genes and acquisition of osteoblast phenotype (29, 73). 
     Several ways can be considered to control osteoblastic activity at implants, such as; 
osteoblast recruitment, attachment, proliferation, and differentiation. These aspects of 
osteoblast physiology are interrelated represent potential targets for clinical improvement of 
bone formation at implant surface (29).  
1.4.1. Osteoblast cell culture systems 
     Osteoblast cell culture model is widely used in osseointegration research. As mentioned 
earlier this model provides an invaluable opportunity to investigate aspects of bone formation 
and cell biology in the laboratory. Several cell lines and culture systems have been developed 
and utilized in investigating the osteoblast activity and interaction at implant surface. Cooper 
and his collaborates categorized these cells according to their origin into  
1. Primary cultures such as bone marrow stromal cells, intramembranous bone, or 
trabecular long bone. 
2. Nontransformed clonal cell lines such as the mouse osteoblast like cells MC3T3-E1. 
3. Osteosarcoma cell lines such as, the human osteosarcoma MG63 cells and the rat 
osteosarcoma ROS 17/2.8 cells. 
4. Intentionally immortalized cell lines such as the rat calvarial cell line RCT-1(31).  
This classification reflects the origin of cell lines, but not the characteristics of each model. 
These different cell lines represent different states of phenotypic maturation in the osteoblast 
lineage and have substantially different levels of homogeneity (17). Nevertheless, in cell 
culture studies the significance and validity of each system depends on the question to be 
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addressed, and the biochemical and molecular properties of the system (31).The osteoblast 
cell lines most commonly used to study the interaction of cells with implant surface include; 
the human osteosarcoma MG63 cells, the mouse osteoblast like MC3T3-E1 cells, the rat 
osteosarcoma osteoblast like ROS 17/2.8 cells, and the fetal rat calvaria FRC cells (17). 
     In the present investigation the mouse osteoblast like MC3Ts-E1 cells were used. These 
cells were originally cultured from newborn mouse calvaria. They have unique features that 
make them a good model to study the mechanisms of biological calcification, osteoblast 
differentiation, and matrix mineralization. The cells have a low alkaline phosphatase (ALP) 
activity in the growing state; however, the enzyme activity will increase in the confluent 
state. This osteogenic cell line has the capacity to differentiate into osteoblasts, osteocytes, 
and deposit minerals in vitro. The cells are capable of showing different stages of growth and 
development under dell culture conditions (79). The pattern of osteogenesis that this cell 
showed in vitro is similar to intramembranous ossification pattern in vivo. The cell 
morphology in the growing state resembles a fibroblast. Nevertheless, when the cells grow 
they start to resemble the osteoblasts in morphology and they can grow in layers (117).In 
intramembranous ossification the process is triggered by the aggregation of undifferentiated 
mesenchymal cells into layers or membranes. These cells synthesize and secrete a loose 
organic matrix that regularly contains blood vessels, fibroblasts, and osteoprogenitor cells. 
The osteoprogenitor cells differentiate into osteoblasts and commence the assembly of 
osteoid (uncalcified bone matrix). This matrix will then mineralize side by side with vascular 
ingrowth to form woven bone that matures into lamellar bone. Similar observations were 
noted by Sennerby and his collaborates around titanium implants placed in rat cortical bone 
(104). Another important feature of the non-transformed osteoblast like cells is that they 
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demonstrate a well-defined inverse relationship between cell differentiation and proliferation 
(114). These unique characteristics make this osteogenic cell line an excellent model to study 
the interaction between the osteoblastic cell and the extracellular matrix (ECM) in vitro. 
 
1.5. Role of cell adhesion in Osseointegration 
      The cell adhesion to extracellular matrix (ECM) proteins and implant surface is a crucial 
and decisive step in peri-implant bone healing process. It is well documented that the cell 
adhesion to the ECM proteins controls complex biological processes, through specific and 
dynamic regulation of cell behavior (35, 40, 53).This critical step is important in 
implementing an appropriate cell response to the implanted material surfaces. 
Biocompatibility of implanted materials is intimately related to the cell behavior in contact 
with them and mostly to cell adhesion to their surface (13). Many studies for example 
showed that the interactions of osteoblasts with their surrounding ECM are essential for 
skeletal development, homeostasis, and for the maintenance of mature osteoblastic phenotype 
(57, 82, 118, 120). 
     After the surgical placement of the endosseous implant, undifferentiated mesenchymal 
stem cells approach the implant material from the bone marrow lining as well as blood and 
tissue fluids. It is extremely critical for these cells to populate the implant surface and to 
continue to proliferate. Moreover, it is even more important for these cells to be committed to 
the osteoblastic lineage and to mature into functional osteoblast to ensure successful 
integration of the endosseous implants. Multiple mechanisms, growth factors, and 
transcriptional factors are involved in this process. However, it is well established that initial 
cell attachment and subsequent cell adhesion to the implant surface play a critical role in 
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these imperative mechanisms (63, 84, 121, 127). The attachment, adhesion and spreading of 
cells are considered the first phase of cell/material interactions and the quality of this phase 
will profoundly impact subsequent central processes such as cell proliferation, migration, and 
phenotypic differentiation(79). 
     Cell adhesion can be divided into two phases. The attachment phase and the adhesion 
phase. Cellular attachment occurs spontaneously with short-term events, like 
physicochemical linkages between the cell and the substrate. The adhesion phase occurs in 
the long term and it involves ECM proteins, cell membrane proteins (adhesion molecules), 
and cytoskeletal proteins. Cytoskeletal proteins are cellular proteins that mediate the 
interaction between the cell membrane receptors and the actin filaments that maintain the cell 
shape. Moreover, these proteins are involved in signal transduction (13, 107). The function of 
these proteins will be discussed in more details in the following section. 
     Cells do not adhere directly to the implant surface. The adhesion is mediated through 
certain proteins that adsorb to the surface. This process starts almost immediately after the 
placement of endosseous implants (97). The preparation of the implantation site will result in 
hematoma which will initiate the clotting cascade. Nevertheless, before the blood clot is 
formed, a number of extracellular matrix proteins will adsorb on the surface of the implant 
from the blood and interstitial tissue fluids at the wound site or from cellular activity at the 
peri-implant region later on (47, 90, 124).This layer of adsorbed proteins converts the foreign 
surface into a biological environment that the cells can sense and respond to. The 
composition of this layer is a key mediator to cell behavior. The presence of particular 
adsorbed proteins can stimulate a beneficial cell response, stimulating wound healing and 
tissue integration, whereas proteins in an unrecognizable state may signify a foreign 
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substance to be removed or isolated (124). As mentioned earlier most of the proteins 
composing this layer are adsorbed from the ECM. Examples of ECM proteins that mediate 
the adhesion of osteoblastic cells with biomaterial surfaces include: fibronectin, vitronectin, 
type 1 collagen, osteopontin, bone sialoprotein, and thrombospondin. These proteins have 
chemotactic or adhesive properties, notably because they contain a ligand sequence of three 
amino acids; Glycine, Aspartic acid, Argenine (Arg-Gly-Asp) that is commonly referred to as 
RGD sequence. This ligand is specific to the fixation of cell membrane receptors like integrin 
that has emerged as a central regulator of cell-biomaterial interactions (13, 47, 107, 124).  
1.6. Integrins as central regulators of osteoblast biomaterial interactions 
     Integrins are a large family of transmembrane receptors that bind specifically to ECM 
proteins. An individual integrin is composed of two non-covalently bonded subunits α and β. 
Therefore they are categorized as being heterodimeric proteins (53). This transmembrane 
receptor family was first recognized by Hynes (55). Each subunit is a glycoprotein that has a 
relatively large extracellular domain and short cytoplasmic domain and a transmembranous 
domain. 
 
 
 
Table 1.4: Length range of the different domains of α and β chains of the integrin 
receptors 
 Length of 
extracellular 
domain 
Length of 
cytoplasmic domain 
Length of 
transmembranous 
domain 
Alpha chain 1008-1152 amino 
acids 
22-32 amino acids 20-29 amino acids 
Beta chain 770 amino acids 20-50 amino acids 26-29 amino acids 
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     Table 1.4 presents the length range of the different domains of both α and β chains of 
integrin receptors.  The extracellular parts of the α and the β chains interact with each other, 
creating a functional heterodimer. Both subunits contain disulfide bridges protecting them 
from proteolysis (107). Mammals contain 18 α and 8 β subunits that combine to produce at 
least 24 distinct heterodimers that have been recognized up to date (41, 53). These proteins 
mediate the interaction between the cells and their surrounding ECM as well as the 
interaction between the cells with each other with the help of other transmembrane receptors 
like cadherins. Moreover, these receptors work as linker proteins to mediate the interaction 
and adhesion of the cells to biomaterial substrates. Integrins are versatile proteins. They span 
the cell membrane and act as an interfacer between intra- and extra- cellular compartments. 
They act as a bidirectional allosteric signaling machine that transmits inside-out and outside-
in signals. They have the ability to translate the attachment of external ligands to internal 
information which induces vital cellular mechanisms. They interact with the ECM and the 
external environment through their extracellular domains, and with components of the cell 
cytoskeleton and signaling molecules through their intracellular domains. It is believed that 
this cross talking regulates important cellular functions, such as; cell adhesion, motility, 
shape, growth, apoptosis, proliferation and differentiation. (13, 36, 41, 54, 107). Figure 1.3 is 
a simple schematic representation of the integrin α and β subunits and their interactions with 
ECM proteins through specific binding ligands and the subsequent signal transduction 
phenomenon that regulates cellular functions. 
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Figure 1.3.: Schematic representation of integrin subunits and signal transduction: 
Integrins bind to specific ECM proteins through specific binding ligands. This activates the 
integrin. The cytoplasmic domain will activate special cytoskeletal structural proteins that are 
part of complex signaling network. These signal transduction pathways will dictate some of 
the vital mechanisms of cell life such as motility, proliferation, differentiation, and 
phenotypic gene expression. 
 
      The sites of adhesion between tissue culture cells and substrate surfaces are called focal 
contacts. Once the integrins are bound to their ligands they move laterally in the plane of the 
membrane to form these specialized clusters or the focal adhesions sites. The external faces 
of these contacts are formed by the integrins. On the internal face special cytoskeletal 
proteins are clustered they include; talin, paxillin, vinculin, and tensin. Many proteins will 
interact with these cytoskeletal components to form special attachment organelles and 
signaling centers. Protein kinases, in particular the focal adhesion kinase (FAK) and 
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phosphatases are crucial enzymes that mediate the phosphorylation of signaling molecules 
activating specific signaling pathways. FAK is a potent signaling molecule with important 
kinase activity. In osteoblast for instance, specific integrin activation results in clustering of 
FAK that starts a cascade of kinase dependant reactions ending in the activation of 
extracellular signal-related kinase (ERK), a mitogen-activated protein kinase (MAPK). 
MAPK is an enzyme that has been implicated in the control of osteoblast-specific gene 
expression and matrix mineralization (36, 99).  Moreover, the activation of integrin also 
results in the organization of the cytoskeleton through rearrangement of actin filaments, 
subsequently affecting cell shape, spreading, adhesion and mobility (13, 41, 53, 107). 
      Regulation of integrin activity also depends on the ECM protein ligand. Signals from 
different ECM ligands will activate different signaling pathways (24). This mode of activity 
is referred to as outside- in signaling. Through this mode of regulation it is suggested that 
implant surface features have the potential to alter the signaling of an integrin receptor. Thus, 
blocking of the integrin function with specific antibodies or soluble peptides will inhibit the 
integrin function and have an impact on the cellular activities regulated through this receptor 
(82, 83, 116).Nevertheless, integrins can be present on cell the membrane in an inactive state 
where they do not bind ligands and do not signal. The activity of the integrin may depend 
upon the ligand, as well as on the integrin. For instance, ligand clustering and conformational 
changes might modulate integrin binding. Nevertheless, some integrins might require a 
second binding site (synergy site) for optimal function. The activation of the synergy site 
might be regulated by intracellular signaling pathways. This mode of integrin activation is 
referred to as inside-out signaling. Furthermore, integrins have the ability to cross-talk with 
other integrins on the cell surface as well as synergistically cooperating with growth factors 
 31
receptors. These synergistic mechanisms play a crucial role in regulation of cellular 
processes such as cycle progression and cell migration (36, 107). The complexity of integrin 
regulation and its diverse function make it a fascinating field of study for cell and molecular 
biologists. In osseointegration research for example, there are some findings that still lack a 
comprehensive explanation; particularly, the roles of integrins in osteoblast- implant 
interaction and its ability to mediate surface specific changes. 
1.6.1. Integrins and osteoblast implant interactions 
     It is well documented that the osteoblast interaction with material surfaces is of 
fundamental relevance and contributes to the clinical success of implants (29, 35, 50, 131). 
Certain implant surface characteristics have been attributed in modulating osteoblast 
behavior, mainly surface chemistry and topography. As discussed earlier, the osteoblast does 
not interact directly with the implant surface. This interaction process is mediated by a layer 
of adsorbed proteins on the surface and by the integrin transmembrane receptors on the cell 
surface. Nevertheless, the exact role that integrins play in mediating osteoblast adhesion to 
the implant surface and its effect on subsequent cell spreading, motility, proliferation, 
differentiation, and matrix mineralization is not completely understood. When examining the 
behavior of osteoblastic cells on surfaces with different roughness controversial results were 
reported. Differential integrin expression was noted on different substrate materials, 
topographies, and among different cell lines (67, 92, 109). It is hard to compare results from 
in vitro studies because of the lack of consensus on the proper representation of implant 
surface topography (28). Moreover, the use of different cell lines, and the use of different 
substrate materials are important factors that contradicts the comparison of in vitro studies 
results.  
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     Many integrin subunits are expressed by osteoblasts. The literature shows that the 
osteoblast expresses integrin subunits α1, α2, α3, α4, α5, α6, αv, β1, β3, and β5 (15, 34, 50, 
109). However, integrin expression by osteoblasts is variable and can differ with the stage of 
development of the osteoblast as well as the cell source (107). Several integrin heterodimers 
are involved in osteoblast interaction with their experimental substrate. The main classes 
include α1β1, α2β1, α5β1, and αvβ3 integrin heterodimers. The integrins α1β1, α2β1 are the 
main collagen binding integrins. Integrin α1β1 has higher affinity to the basement membrane 
type IV collagen. While, integrin α2β1 binds to type 1 collagen which is the dominant bone 
matrix protein .Gronthos and collaborates, documented that β1 integrins are the most 
predominant adhesion receptor utilized by osteoblast-like cells to adhere to the collagen 
matrix particularly α2β1 heterodimer(51). Moreover, several other studies indicated that the 
interaction of α2β1 with type I collagen is crucial for signal induction of osteoblastic 
differentiation and matrix mineralization (57, 82, 99, 118, 120, 128). On the other hand, the 
α5β1 pair is selective for fibronectin, and this interaction has also been identified as central to 
osteoblastic function (48, 83, 84, 116). The integrin pair αvβ3 can bind to multiple ligands 
including vitronectin, fibronectin, osteopontin, and bone sialoprotein (BSP) (13, 98, 107). 
The coordinated expression of β3 integrin with BSP which is a well documented determinant 
of osteoblast differentiation and bone formation gives the illusion that this selective β3-
integrin/BSP adhesion mediated signaling may play a significant role in osteoblast morpho-
differentiation (32, 98).   Nevertheless, unlike β1 integrin the role of β3 integrin in osteoblast 
biomaterial interaction has not been extensively investigated.  The ability of certain integrin 
heterodimers to interact selectively with a certain protein ligands is a key factor in 
determining the cellular response to biomaterial interaction. The fact that there are multiple 
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integrin heterodimers mediating osteoblast substrate interaction provides the potential of 
regulating different cellular responses, depending on the integrin receptor expressed by the 
cell and the composition of the surrounding ECM.  
     The composition and the conformation of the extracellular adsorbed protein layer is 
thought to be the primary factor determining the cell response to biomaterial specification 
including surface chemistry, topography, charge, and wettability (13, 107, 124). Nonetheless, 
there is a growing evidence suggesting that substrate properties themselves are what 
determine the conformation and composition of the adsorbed protein layer, ECM production 
of adherent cells, and consequently the integrin receptor expressed (56, 63, 78, 102, 109). 
Besides, there is some evidence to show differential pattern of integrin expression at different 
stages of cellular maturation (15). Schneider and collaborates, for example, using a fetal 
bovine osteoblast culture model observed a restricted expression of αvβ3 integrin to days 3 
and 5 in the cell culture in comparison to a generalized expression of α5β1 integrin over the 2 
weeks culture period. (98).Therefore, understanding the basic role that integrin receptors play 
in osteoblast implant interaction and identifying the basic subunits that are involved in this 
process is fundamental for enhancing our understanding of osseointegration process. Another 
issue of critical importance is the ability to identify the particular ECM ligands for each 
integrin heterodimer, their mode of expression, and the cellular processes they mediate. A 
better understanding of these essential mechanisms will enhance our ability to engineer 
bioactive surfaces that can be used for biomedical and biotechnological purposes (46, 47) 
     The use of blocking antibodies against specific integrin subunits, or against a specific 
ECM protein ligand to disrupt cell substrate interaction and perturb integrin function, is a 
recommended procedure to analyze adhesive interactions to biomaterials. This procedure has 
 34
been utilized to identify specific integrin subunits and integrin-ligand pairs that mediate 
osteoblast adhesion to biomaterials and their influence on vital cellular mechanisms. (57, 82-
84, 99, 108, 116, 128). This method will be used in this research project to evaluate the effect 
of β1 and β3 integrin subunits on the early interaction of osteoblast like cells (MC3T3-E1) 
with commercially pure titanium surfaces of different surface topographies. 
 
1.7. Goals and specific aims 
          Implant surface features affect bone formation and adherent cellular activities. The 
integrin transmembrane receptors particularly β1 and β3 receptors have emerged as central 
regulators of cell biomaterial interactions. Nevertheless, the exact role that these receptors 
play in modulating osteoblast behavior on different implant surfaces is not completely 
understood. The goals of this in vitro investigation are: 
1. To examine the ability of β1, β 3 integrin antibodies to disrupt cp Titanium surface-
specific responses of MC3T3-E1 cells with particular emphasis on cell:  
a. Adhesion 
b. Spreading 
c. Proliferation 
d. Differentiation 
2. To compare MC3T3-E1 early cell adhesion to cp titanium, and proliferation in the 
presence and absence of β1, β 3 integrin function as a function of time and surface. 
3. To quantify and compare the early expression of osteogenesis related genes with and 
without β 1, β 3 monoclonal antibody as a function of surface roughness. 
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1.8. Hypotheses 
1. If β1 and or β3 integrins mediate surface-specific changes in osseointegration, then 
blocking of integrin interactions with implant surfaces will have surface-specific 
effects on cellular adhesion and osteoblast-specific gene expression. 
2. Both β1 and β3 integrins have substantial effect on the early interaction between 
osteoblast like cells and implant surface in vitro. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 2 
MATERIALS AND METHODS 
 
2.1. Commercially pure titanium surface preparation 
     Commercially pure grade IV titanium (cpTi) disks were provided by the University of 
North Carolina (UNC) Dental Research Center, bone biology and implant therapy laboratory. 
The disks were 13 mm in diameter and 2 mm thick. Disks were randomly selected to prepare 
two different surface roughnesses, smooth (turned) and rough (sandblasted and hydrochloric 
acid etched). All disks were initially prepared by polishing using silicone carbide abrasive 
paper (3M, Saint Paul, MN). Disks were gradually polished by 200,400 and 600 grit carbide 
abrasive papers in a consecutive manner. While the disks were polished they were washed 
consequently with 70% ethanol to clean the debris and to minimize heat production. 
Afterwards, the disks were washed thoroughly using distilled water. The disks that were 
randomly selected to have smooth surface topography were ultrasonically cleaned using 
deionized distilled water (ddH2O). The disks went through 5 phases of ultrasonic cleaning 
for 5 minutes duration for each phase. The ddH2O was changed each time and the disks were 
further washed and rinsed thoroughly in ddH2O between phases. 
      The rough surface were prepared and passivated according to the preparation method 
proposed by Keller et al (62). Disks were further grit-blasted with 100 μm aluminum oxide 
Al2O3 particles using a sandblasting machine (MicroBlaster, Comco Inc, Burbank, CA). 
Afterwards, sandblasted surfaces were washed with ddH2O, ultrasonically cleaned five 
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times, 5 minutes each time with ddH2O in a similar fashion to the smooth surfaces. Then the 
disks were acid etched with 5 mol/L hydrochloric acid (5N HCL) overnight. This procedure 
will result in grit blasted acid etched surface of the micron-scale level of roughness (4). 
     Finally, both smooth and rough surface disks were rinsed and washed thoroughly using 
ddH2O and passivated by soaking the disks 40% nitric acid for 5 minutes. After the 
passivation process, the disks were further washed by ddH2O and then were soaked in 70% 
alcohol for at least 24 hours. Prior to cell plating, the disks were exposed to ultraviolet light 
in a sterile tissue culture hood for 24 hours to dry and sterilize the disks.  
2.2. Surface analysis 
     To gain more detailed information regarding the prepared surfaces topography, a surface 
analysis was conducted using atomic force microscopy (AFM). Disks were subjected to 
AFM analysis (AFM; Auto Probe CP, Park Scientific Instruments, Sunnyvale, CA). The 
atomic force microscope uses a non-contacting stylus to image the surface of the disks and 
create a digitized image from which numerous surface parameters can be calculated. Scans 
(50μm X 50μm) were made for each surface, and three disks were analyzed for each 
individual surface. Packaged algorithms provided calculations for area statistics, which 
included average roughness (Rа) and root mean square roughness (RMS). Average roughness 
(Ra) is the most commonly reported surface parameter and it represents the arithmetic mean 
of deviations in the roughness profile from the mean line (91). On the other hand, RMS 
represents the standard deviation of the distribution of surface heights. It is important 
parameter to describe surface roughness by statistical methods. 
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2.3. Cells and cell culture 
     The MC3T3-E1 osteogenic cell line (American type culture collection, Manassas, VA) 
was used in this project. The cells were maintained in Gibco Minimal Essential Medium 
Eagle, Alpha modification (α-MEM) (Invitrogen Corporation, Carlsbad, CA).  The medium 
was supplemented with 10% fetal bovine heat inactivated serum (FBS) (Invitrogen 
Corporation, Carlsbad, CA) and 1% antibiotics (penicillin/streptomycin) and antimicotic 
agents (Sigma, Saint Luis, Missouri). The cells were cultured in a fully humidified 
atmosphere consisting of 95% air, 5% CO2 at 37°C. The cells were passaged every third day. 
Cells at 90% confluent were removed by using Trypsin/EDTA reagent (Sigma, Saint Louis, 
Missouri). At the time of the experiments the cells were centrifuged at 1200 rpm for 4 
minutes, suspended in complete medium counted and prepared for each experiment. Each 
experimental condition was performed in triplicate for statistical confidence.  
 
2.4. Cell treatment with monoclonal antibodies and IgG control 
        Before plating the cells on the disks for both the molecular and morphological studies, 
the cells were treated with either specific monoclonal antibodies for β1 and β 3 integrin 
subunits or with control immunoglobulin G antibody (IgG). After the cells were trypsnized, 
counted, and centrifuged, they were resuspended in medium to provide the concentration of 
cells needed for the particular experiment. Afterwards, the cells were centrifuged again at 
1200 rpm for 4 minutes and the medium was removed. The cell pellet was resuspended in 
media containing the specific monoclonal antibody or the IgG control at the defined 
concentration. 
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         Monoclonal anti-mouse integrin β1/ CD29 antibody (R&D systems, Minneapolis, MN) 
was used to block integrin β1 function. The stock solution was diluted with 0.2 ml of ice cold 
1X Phosphate buffered saline (PBS).This resulted in an antibody concentration of 500 μg/ml. 
Moreover, monoclonal anti- β3 CD61 mouse antibody (Fitzgerald industries international 
incorporation, Concord, MA) was used to block β3 integrin function. The stock solution was 
reconstituted with 1 ml of ice cold 1X PBS that resulted in a concentration of 500 μg/ml. 
Finally, for the control groups a Rat IgG isotype control antibody (R&D systems, 
Minneapolis, MN) was used. The stock solution was reconstituted with 1ml of ice cold PBS 
to produce a concentration of 500 μg/ml. For each of the three reagents, 60 μg was needed to 
treat one million cells. The cell pellet after centrifuging was washed twice with ice cold 1X 
PBS and was resuspended in the solution containing either the anti- β1 monoclonal antibody, 
anti- β3 monoclonal antibody, or the IgG isotype control. The tubes were kept in a cell 
culture incubator at 37°C with intermittent agitation. After one hour α-MEM was added to 
produce a concentration of 20 μg/ml for the three reagents in the RT² Profiler™ PCR Arrays 
experiment, and 8 μg/ml for the SEM experiment. For both the molecular and the 
morphological studies cells were resuspended in 300 μl media for plating on each disk. This 
resulted in final concentration of 6 μg/ 100,000 cells for the molecular study and 2.4 
μg/40,000 cells for the morphological study.  
 
2.5. Osteogenesis gene expression profiling with RT² Profiler™ PCR Arrays 
experiment 
 
     After the completion of the cell treatment with anti- β1 monoclonal antibody, anti- β3 
monoclonal antibody, or IgG isotype control and the addition of the required amount of α-
MEM medium, the cells were mixed thoroughly and were ready to be plated. This 
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experiment was performed twice; once the cells were treated with anti- β1 monoclonal 
antibody in the test group and the second time cells were treated with anti-β3 monoclonal 
antibody in the test group. In both experimental conditions, cells in the control groups were 
treated with IgG isotype control. Having two different surface preparations (rough, smooth) 
and two different cell treatment protocols (anti β1/ β3, Control) resulted in four different 
groups in each experimental condition (Figure 2.1). 
 
 
 
Figure 2.1.: A flow chart representing the experimental design for The SEM and the 
RT² Profiler™ PCR Arrays experiments. 
 
     The cells were seeded on the disks with a density of 105 cells/ disk in 300 μl volume of 
medium. Seven disks were used for each group the disks were placed in cell culture plates 
and incubated in fully humidified atmosphere consisting of 95% air, 5% CO2 at 37°C for 24 
hours. The cells were allowed to attach initially to the surface for 3 hours and after 3 hours α-
MEM medium was added to cell culture plates until the disks were completely covered and 
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were placed back in the incubator for the remainder of the 24 hour culture period. After 24 
hours, the cells were harvested using TRI REAGENT™ (Sigma, Saint Louis, Missouri).This 
reagent is a mixture of guanidine, thiocyanate, and phenol in a mono-phase solution. After 
the removal of the medium the disks were washed twice with ice cold 1X PBS, then the cells 
were harvested carefully using the TRI REAGENT™ and were ready for ribonucleic acid 
(RNA) isolation. After the cells were homogenized in TRI REAGENT, samples were stored 
at -70 °C till the time of RNA isolation less than a week after the completion of the 
experiment. 
2.5.1. RNA isolation and first strand cDNA synthesis 
     Total RNA was isolated from cell layers using TRI REAGENT™ (Sigma, Saint Louis, 
Missouri ), based on the single-step method described by Chomczynski and Sacchi (26).  
1. The homogeneous mix sample was allowed to stand for 5 minutes at room 
temperature. Afterwards, 0.2 ml of chloroform was added per ml of TRI REAGENT 
used.  The resulting mix was centrifuged at 12,000 x g for 10 minutes at 4 °C mix. 
Centrifugation separates the mixture into 3 phases: a red organic phase (containing 
protein), an interface (containing DNA), and a colorless upper aqueous phase 
(containing RNA). 
2. The aqueous phase was transferred to fresh tube and 0.5 ml of isopropanol per ml of 
TRI REAGENT used in sample preparation. The resulting mixture was allowed to 
stand for 5-10 minutes at room temperature, and then it was centrifuged at 12,000 g 
for 10 minutes at 4°C. This step precipitated the RNA which formed a pellet on the 
side and bottom of the tube. 
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3. The supernatant was removed and the RNA pellet was washed with 75% ethanol per 
1 ml of TRI REAGENT used in sample preparation. The mix was then shaked 
vigorously using Vortex and then it was centrifuged at 7,500 x g for 5 minutes at 4°C. 
4.  The RNA was air dried for 5-10 minutes without completely drying the pellet. 
Afterwards, the RNA was redissolved using 10-20μl of RNase free 
diethylpyrocarbonate (DEPC) water. To facilitate the dissolution, the liquid was 
mixed by repeated pipetting at 55-60 °C for 10-15 minutes. 
5.  The RNA was quantified by UV spectrophotometry (Beckmann DU-600). One μg of 
total RNA was needed to make cDNA using RT² first stand kit (SuperArray, 
Bioscience Corporation, Fredrick, MD) for each 96-well plate formats of RT² 
Profiler™ PCR Arrays. 
6. For cDNA synthesis a genomic DNA elimination mixture was prepared by mixing 
total RNA with GE reagent (5x gDNA elimination buffer) and DPEC water. The 
mixture was incubated at 42 °C for 5 minutes and chilled immediately on ice. 
Afterwards 10 μl of the Reverse transcriptase (RT) cocktail was added to 10 μl of 
genomic DNA elimination mixture and they were mixed very well using a pipettor 
and were incubated at 42 °C for 15 minutes. Afterwards, they were heated to 95 °C 
for 5 minutes to degrade the RNA and to inactivate the reverse transcriptase. Finally, 
91μl of ddH2O was added to each 20 μl of cDNA synthesis reaction. They were 
mixed well and the finished first strand cDNA was stored at -20 °C. The cDNA for 
each experimental group was equally divided into 3 samples to perform the PCR 
array in triplicate format.   
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2.5.2. Performing Real-Time PCR using RT²Profiler™ PCR Arrays 
          To determine the relative differences in gene expression of osteogenesis specific genes 
the mouse osteogenesis RT²Profiler™ PCR Arrays system was used. This system brings 
together the quantitative performance of real-time PCR and the multiple gene profiling 
capability of microarrays. This PCR array profiles the expression of a panel of 84 genes 
related to osteogenic differentiation, skeletal development, bone and mineral metabolism, 
growth factors, cell adhesion and extracellular matrix molecules related to bone 
development, and genes mediating osteogenesis, cell proliferation, growth , and 
differentiation. The whole list of genes included in this array is represented in appendix A. 
The protocol for performing the PCR array took about two hours for each sample. The PCR 
was done in triplicate for each experimental or control group for statistical confidence. This 
resulted in 12 samples for the anti- β1 experiment and another 12 samples for the anti- β3 
experiment.  
     For each sample (PCR plate) 102μl of diluted first strand cDNA was mixed with 1275 μl 
of 2X superArray RT² qPCR master mix and 1173 μl of ddH2O, this resulted in 2550 μl of 
total volume. Equal aliquots of 25 μl were added to the 96 wells containing the pre-dispensed 
gene-specific primer sets using a multi channel pipette and the wells were covered tightly 
with a plastic led. PCR was performed using ABI prism 7000 real-time PCR thermocycler. 
The instrument’s software was used to calculate the threshold cycle (Ct) values for all genes 
on each PCR array. Five internal control genes presented in PCR array were used for 
normalization. A simple examination of Ct value consistency of these internal control genes 
quickly indicated the proper normalization method. Fold changes in gene expression for pair-
wise comparison was calculated using comparative Ct method (∆∆ Ct method). This method 
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was used to calculate the relative amount of the transcripts in the experimental sample and 
the control sample, both of which were normalized to the internal controls. ∆ Ct is the log2 
difference in Ct between the gene and internal controls, ∆∆ Ct= ∆Ct (experimental)-∆Ct 
(control) for biological RNA samples (69).  
 
 
2.6. Cell binding experiment using scanning electron microscopy 
       Evaluation of the effect of anti-β1 and anti- β3 monoclonal antibodies, time, and surface 
topography on MC3T3-E1 initial cell binding to Cp titanium surfaces as well as cell 
spreading were examined both quantitatively and qualitatively using SEM. The experimental 
design was similar to the PCR array experiment (figure 2.1). However, the effect of time on 
the initial cell binding and spreading was evaluated at 3 different time points for all different 
experimental groups (2 hours, 4 hours, and 24 hours). Unlike the PCR array experiment, anti- 
β1 and anti- β3 and control (IgG) were evaluated on both smooth and rough Cp titanium 
surfaces in the same experiment. This resulted in six different experimental groups that were 
evaluated at three different time points (figure 2.1). Two disks were used for each group at 
any single time point. The cells were treated with either anti- β1 or anti- β3 and IgG isotype 
control in a similar fashion to the PCR array experiment. However, only 40,000 cells in 300 
μl of medium were plated on each disk to decrease cell density and be able to identify 
individual cells when performing the SEM. 
 
 
 
 45
2.6.1. SEM preparation 
       After plating the cells on the disk, adherent cells and disks at the particular time points 
were rinsed three times with ice cold 1X PBS and fixed for 60 minutes with 4 % Para- 
formaldehyde and left at room temperature for one hour, then they were refrigerated a -4 °C 
for at least 24 hours. For the 4 and 24 hour groups α-MEM medium was added to cover the 
disks after 3 hours, then it was removed before washing the adherent cells and disks with 1X 
PBS and fixation with paraformaldehyde. After fixation for 24 hours the paraformaldehyde 
was removed and the disks were further washed three times with ice cold 1X for 15 minutes 
each time. Afterwards, the disks and adherent cells were dehydrated using graded ethanol 
solutions from 50% to 100% for 15 minutes each time in a 12 well-plate. The 100% ethanol 
step was repeated for 3 times. After the last 100% ethanol drying step, 2 ml of 
hexamethyldisilazane (HDMS) (Electron microscopy sciences, Fort Washington, PA) was 
added for each well and let to evaporate overnight under a fume hood for complete 
dehydration. Before performing the SEM imaging the samples were coated with conductive 
material according to SEM manufacturer recommendation. Hitachi S-4700 Scanning electron 
microscope (Hitachi High Technologies America, inc., Pleasanton, CA) was used to obtain 
SEM images for the different groups. 
 
2.6.2. Quantitative and qualitative evaluation of osteoblast like cell adhesion, spreading 
and morphology on Cp titanium surfaces 
 
     Cell adhesion was determined by averaging the number of the cells counted at low 
magnification (X 300) from three random areas per disk. Two disks were used for each group 
at any particular time point. The number of cells was counted three times by three different 
investigators working independently and who were blinded to the experimental group for 
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each sample. The investigators were calibrated before performing the cell counting process 
and inter-examiner reliability test showed a very good agreement among the three 
investigators (Kappa value 0.78). This protocol resulted in 18 readings for any experimental 
group at any particular time point. Descriptive statistics were calculated for each group using 
SPSS software (SPSS inc. Chicago, Illinois) and comparisons among groups and between 
particular groups were performed. Furthermore, the spreading of the cells was evaluated by 
using the presence of cell processes, elongation of the central cytoplasm region, cell diameter 
at its longest axis as criteria for spread cell to score the cell morphology manually. Cells that 
scored 20 μm or more in its longest dimension as determined by the scale on SEM images, 
were considered as spread cells and the ones that scored less than 20 μm, were considered as 
round cells. Data acquisition and analysis for round and spread cells were performed in 
identical fashion to total number of cells with three blind investigators counting cells 
independently. 
     SEM images at higher magnification (X 2000) for all experimental groups were made to 
evaluate cell shape, spreading and attachment for subjective comparison among different 
surfaces and treatment protocols. 
 
2.7. Statistical analysis 
     For the RT² Profiler™ PCR Arrays experiment, a specific data analysis web portal provided 
by the PCR arrays system was used to perform the data analysis. This web portal 
automatically performs calculations and interpretations of the control wells upon including 
threshold cycle data from the real-time PCR instrument. Statistical comparisons between fold 
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changes among any two groups were performed using T-test and any p-value less than 0.05 
was considered statistically significant.  
     As for the quantitative analysis of cell adhesion and spreading using SEM, SPSS software 
was used to analyze the raw data. Descriptive statistics comparisons were performed for the 
different experimental groups. Moreover, factorial ANOVA was used to compare the mean 
number of total, spread, and round cells among the different experimental groups and at 
different time points and any P value less that 0.05 was considered statistically significant. 
For pair wise comparisons between individual groups post-hoc Tuckey test was used and any 
p value less than 0.05 was considered statistically significant.   
 
 
  
 
CHAPTER 3 
RESULTS 
 
3.1. Atomic force microscopy surface analysis 
     AFM analysis of the disks provided measures of average surface roughness (Ra) and root 
mean square roughness, for comparisons among individual surfaces (Table 3.1). Each surface 
displayed a unique topography (Figure 3.1). Smooth surfaces had relatively low peak-to-
valley measurements compared to rough surfaces. Moreover, the Ra and RMS values were 
considerably greater for rough surfaces compared to smooth surfaces. 
Table 3.1: Surface parameter measurements as calculated by atomic force microscopy 
for smooth and rough surfaces. 
 
Surface Ra RMS 
Rough 0.39 (± 0.019) μm 0.46 (±0.027) μm 
Smooth 0.036 (± 0.006) μm 0.047 (± 0.007) μm 
  
Ra: average surface roughness, RMS: root mean square roughness. Data presented as the 
mean (± Standard error of the mean). 
 
 
    Atomic force microscopy representative images of 50 μm X 50 μm of the test surfaces for 
surface parameters analysis are presented in figure 3.1. 
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Figure 3.1: Atomic force microscopy surface topography analyses representative of 50 
μm X 50 μm areas of test surfaces ( A: Rough surface, B: Smooth surface). 
 
  
 3.2. Initial cell attachment and total cell count 
     The number of total cells per surface area was measured as a function of cell attachment 
to the cpTi surfaces. The input number of cells was held constant in this experiment. Mean 
number of adherent cells in the different experimental groups at three different time points on 
both smooth and rough surfaces are shown in figure 3.2. 
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Figure 3.2. : Mean number of cells at different time points among the different 
experimental groups on both smooth and rough surfaces. 
S: smooth surface, R: Rough surface 
 
     The number of cells in the control group is slightly higher on rough surface than smooth 
surface and they increase slightly at 24 hours in comparison to 2, 4 hours. Nevertheless, in 
the anti-β1 and anit-β3 groups the cell numbers initially at the 2 hours time point are less than 
the control group and they increase with time on the smooth surface particularly in the anti- 
β1 group where cell numbers return to the level of the control group at 24 hours. On the other 
hand, cells decrease in number on rough surface between 4 and 24 hours in the anti- β3 group 
and did not change in the anti- β1 group. Nonetheless, when performing factorial ANOVA 
statistical test, the only factor which had a significant influence on number of cells was 
treatment (anti- β1 Ab, anti- β3 Ab, or IgG control). Figure 3.3 shows the mean number of 
cells at different time points among the different experimental groups on both surfaces. 
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Figure 3.3.: Clustered bar chart showing the mean number of cells among the different 
experimental groups on both smooth and rough surfaces. 
 
     The control group had higher number of cells than the anti-β1 or the anti- β3 groups on 
both surfaces and at all time points except for the anti- β1 group at 24 hours on smooth 
surface. However, the difference was only statistically significant at 24 hours on rough 
surface as determined by post-hoc Tuckey test. Moreover, smooth surface has significantly 
higher number of adherent cells at 24 hours than rough surface in the anti-β3 group as 
determined by one way ANOVA statistical test. 
3.3. Initial cell spreading and spread and round cell counts 
     Cell spreading was evaluated by measuring the number of spread cells versus round or 
spherical cells. The presence of cell processes the elongation of the cytoplasm and the ability 
of the cell to spread for more than 20 μm  as measured by the cell longest dimension were 
considered as surrogates for cell spreading. Figure 3.4 shows the mean number of spread 
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cells at different time points among the different experimental groups on both smooth and 
rough surfaces. 
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Figure 3.4.: Mean number of spread cells at different time points among the different 
experimental groups on both smooth and rough surfaces. 
S: Smooth surface, R: Rough surface 
       
     In the control group numbers of spread cells on both surfaces were higher than for the 
anti-β1 and the anti- β3 groups. However, cells in the control group adherent to the rough 
surface decreased from 2 to 4 hours then increased at the 24 hour mark. Notably, spread cells 
on smooth surface where higher than on rough surface. Similar finding was noted in the anti- 
β1 and anti- β3 groups with more spread cells in the anti- β3 group than anti- β1 group and 
more spread cells on smooth versus rough surface. Another finding was that cells slightly 
increased between the 4 and 24 hour time points in the anti- β1 group. On the other hand, 
they decreased in the anti- β3 group particularly on rough surface. Nonetheless, when 
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factorial ANOVA statistical test was performed, the only factor that had a significant 
influence on number of spread cells was treatment (anti- β1 Ab, anti- β3 Ab, or IgG 
control).Figure 3.5 shows the mean number of spread cells on both surfaces at the different 
time points among the different experimental groups.  
 
 
Figure 3.5.: Clustered bar chart showing the mean number of spread cells among the 
different experimental groups on both smooth and rough surfaces. 
      
     The control group had higher number of spread cells than anti- β1 and anti- β3 groups on 
both surfaces at all time points. Nevertheless, the difference was only significant at 2 hours 
on both surfaces and at 24 hours on rough surface only, as determined by post-hoc Tuckey 
test. The mean number of  round or spherical cells at different time points among the 
different experimental groups are shown in figure 3.6. 
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Figure 3.6 .: Mean number of round cells at different time points among the different 
experimental groups on both smooth and rough surfaces. 
S: Smooth surface, R: Rough surface 
     This figure shows that the control group on both smooth and rough surfaces has less 
number of round cells in comparison to the anti-β1 and the anti- β3 groups although round 
cell number on rough surface increased at the 4 hours mark on rough surface but they 
decreased on the 24 hours mark. Moreover, round cells were higher on rough surface in 
comparison to smooth surface. This observation was also noticed in the anti- β1 and the anti- 
β3 groups although at the 24 hour mark the highest number of round cells was measured at 
the smooth surface in the anti- β1 group. Another observation was that in both anti- β1 and 
anti- β3 groups round cell number decreased between the 4 and 24 hour time points on rough 
surface and increased on smooth surface.  
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     When factorial ANOVA statistical test was performed the factors that had significant 
influence on number of round cells where treatment (P value<0.0001) and surface (p 
value<0.05). When post-hoc Tuckey test was performed for pair wise comparisons, anti-β1 
group had a significant higher number of round cells on rough surface than both anit-β3 
group and the control group at the 2 and 24 hours time points. Nevertheless, anti-β3 had a 
significantly higher number of adherent round cells on smooth surface at the 2 hour time 
point than the anti-β1 and the control groups. Furthermore, one way ANOVA statistical test 
was performed for pair wise comparisons of the different experimental groups on both 
surfaces. These comparisons showed that the anti-β1 and the  control groups had significantly 
higher number of round cells on rough surface than on smooth surface at the 2 and 4 hours 
time points (figure 3.7). 
 
Figure 3.7: Box plot graph showing the mean number of round cells among the 
different experimental groups on both smooth and rough surfaces.         
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      Different examples of SEM images that were used for counting the number of total, 
spread, and round cells are shown in figure 3.8. These sections show that the experimental 
groups anti-β1 and anti- β3 had less number of cells and higher number of round cells or cells 
that couldn’t spread enough on the surface. 
 
 
Figure 3.8.: Examples of SEM images from different experimental groups and different 
time points that were used for data acquisition. Blue arrows: Spread cells. Red arrows: 
round cells 
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3.4. Subjective evaluation of SEM images at higher magnification 
      SEM images were made at higher magnification (X 2000) for subjective evaluation of the 
cell shape, spread, and interaction of the surface. Some examples of the SEM images are 
shown in figure 3.9.The highly magnified SEM images show that cells adhere differently on 
smooth and rough surfaces. By comparing images A and B the cells on both surfaces did 
spread over the surface. However, the cell on the smooth surface had still a round cytoplasm 
and less number of cell processes attaching the cell to the surface and it seems as if it is 
raised over the surface. On the other hand, cells on rough surface at the same time point had a 
more elongated cytoplasm and processes and they looked as if they were closely adapted to 
the configurations of the surface. 
     Similar findings can be observed when comparing images C and D. Cells on images C 
and D are round and couldn’t spread over the surfaces Nonetheless, these cells still could 
attach to the surface. Nevertheless, cells on the rough surface seem to have better ability to 
attach to the surface and to develop more cellular processes even earlier in the process. Image 
F shows cells that were treated with anti-β3 antibody; both cells were round and didn’t 
spread over the surface. However, one of the cells attached better to the surface (rough) with 
multiple processes and better adaptation to surface configurations. On the other hand, the 
other cell was probably only mechanically retained by the pits and irregularities produced by 
surface treatment. Finally, image E shows that cells were differentially affected by the anti-
β3 treatment. One cell could spread over the surface and the other did not. However, both of 
them developed some processes to attach them to the surface although the images show that 
they were less intimately attached to the smooth surface in comparison to the rough. 
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Figure 3.9.: SEM images at higher magnification (X 2000). 
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3.5. RT²Profiler™ PCR Arrays results 
            Mouse RT²Profiler™ PCR Arrays system was used to determine the relative 
differences in gene expression of a panel of 84 genes associated with the process of 
osteogenesis. This system profiles the expression of genes from different functional groups 
related to many cellular activities such as skeletal development, bone mineral metabolism, 
cell growth and differentiation, ECM proteins, cell adhesion molecules, collagen proteins, 
and transcriptional factors and regulators. A complete list of all genes available in this system 
is presented in appendix A. Nevertheless, for easier presentation of data, selective classes of 
functional genes will be considered in the data analysis. Table 3.2., presents the functional 
group of genes and the genes that showed significant changes among different experimental 
groups. 
Table 3.2: Functional group of genes and genes that presented significant changes 
among different experimental groups (significant: either statistically significant or has 
more that 2 fold difference in mRNA expression). 
 
Functional group of genes Genes presented significant 
changes (anti-β1) 
Genes presented 
significant changes  
(anti-β3) 
Bone morphogenic protein 
superfamily 
Tgfβ1, Bmp2, Bmp6 Gdf10,Bmp2, Bmp3, Bmp5, 
Bmp6 
Bone matrix proteins Ambn, Sost, Ahsg, ALP Ambn, Sost, Ahsg, ALP 
Integrin receptors Itgα2, Itgβ1, Itgαv  
Growth factors Vegfa, Vegfb, pdgfα, fgf3, 
Csf2,Csf3 
Vegfa, Fgf2,Fgf3, Egf, 
Csf2,Csf3 
Transcriptional factors Smad4,Runx2, Msx1, Twist1 Msx1 
 
     In the following sections the fold difference in mRNA expression between the anti-
β1/anti-β3 and the control group on both smooth and rough surfaces will be presented for 
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selective functional gene groups. Furthermore, the group of genes which are not presented in 
the following sections showed similar trends. 
3.5.1. Bone morphogenic protein superfamily 
     The bone morphogenetic proteins (Bmps) are a family of secreted signaling molecules 
that can induce ectopic bone growth. Many Bmps are part of the transforming growth factor-
beta (Tgfβ) superfamily. Bmps were originally identified by an ability of demineralized bone 
extract to induce endochondral osteogenesis in vivo in an extraskeletal site.  Figures 3.10 and 
3.11 represent bar graph charts of fold difference in mRNA expression of Bmp superfamily 
genes between the anti-β1/anti-β3 and the control group on both smooth and rough surfaces. 
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Figure 3.10: Bar graph showing the difference in mRNA expression of Bmp 
superfamily genes between anti-β1 and control groups on both smooth and rough 
surfaces. 
R: rough surface, S: smooth surface. 
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Figure 3.11: Bar graph showing the difference in mRNA expression of Bmp 
superfamily genes between anti-β3 and control groups on both smooth and rough 
surfaces. 
R: rough surface, S: smooth surface. 
 
      The results show that there is a different trend in Bmp superfamily gene expression when 
β1 and β3 integrins were blocked with specific antibodies particularly on smooth surface 
(Figure 3.10, 3.11). Pre-treatment of MC3T3-E1 cells with anti- β1 antibody on smooth 
surface resulted in down regulation of the Bmp superfamily gene expression of about 2 folds, 
with the exception of Bmp2, and Gdf10 which were up-regulated. On the contrary, when 
cells were pretreated with anti- β3 antibody, all Bmp superfamily genes were up- regulated 
on smooth surface and Bmp5 and Bmp6 were significantly up- regulated.  Nevertheless, on 
rough surface, Bmp superfamily gene expression show a similar trend, when cells were 
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pretreated with anti-β1 and anti- β3 antibodies. All Bmp superfamily genes in the anti- β1 
group were up-regulated or rough surface with Bmp2 and Bmp6 significantly up regulated 
(more than 8 folds) and Bmp3 and Bmp5 with more that 4 folds of up-regulation . In the anti- 
β3 group all Bmp superfamily genes were significantly up-regulated (over 4 folds) with the 
exception of Tgfβ.  
3.5.2. Bone matrix proteins 
      This group of genes contains some of the matrix proteins that are associated with 
osteogenesis and tissue development. Alkaline phosphatase (ALP) is a tetrameric 
glycoprotein found on the surface of osteoblast and is responsible for laying down matrix for 
bone. It is considered as a marker for early bone formation. Sclerostin (Sost) is a secreted 
glycoprotein that works as a Bmp antagonist. A mutation in the Sost gene is associated with 
an autosomal recessive disorder called sclerosteosis which causes progressive bone 
overgrowth. Alpha-2-HS-glycoprotein (Ahsg) is a glycoprotein that is present in serum and is 
involved in bone development and formation as well as development of other tissues. Finally, 
Biglycan (Bgn) is a cellular or peri-cellular proteoglycan, it is thought to function in 
connective tissue metabolism by binding to collagen fibrils and Tgfβ. Figures 3.12 and 3.13 
represent bar graph charts of fold difference in mRNA expression of these bone matrix 
proteins between the anti-β1/anti-β3 and the control group on both surfaces.  
 63
-4 -2 0 2 4 6 8 10 12
ALP
Bgn
Ahsg
Sost
G
en
e
Fold difference in gene induction
R Aβ1/R
S Aβ1/S
 
Figure 3.12: Bar graph showing the difference in mRNA expression of bone matrix 
proteins between anti-β1 and control groups on both smooth and rough surfaces. 
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Figure 3.13: Bar graph showing the difference in mRNA expression of bone matrix 
proteins between anti-β3 and control groups on both smooth and rough surfaces. 
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     Figures 3.12 and 3.13 show similar trends in bone matrix proteins gene expression in both 
anti- β1 and anti- β3 experiments. When MC3T3-E1 were pre-treated with anti- β1 antibody 
bone matrix proteins gene expression were slightly down regulated on smooth surface with 
the exception of  Sost and Bgn that were slightly up-regulated . Nevertheless, these 
differences were not statistically significant. On the contrary, on rough surfaces all bone 
matrix proteins showed up regulation in gene expression specifically Sost, and ALP that had 
at least 4 or more fold increase in gene expression (figure 3.12). Likewise, when MC3T3-E1 
cells were pre-treated with anti- β3 antibody similar findings were noted. On smooth surface, 
bone matrix proteins were not regulated without any significant changes in gene expression 
except for Sost that had 2 fold increase in gene expression. Yet, on rough surface the 
difference was more pronounced and bone matrix proteins gene expression show a highly 
significant up regulation with 4 fold or more with the exception of Bgn which didn’t show a 
marked difference in gene expression (figure 3.13). 
3.5.3. Growth factors 
     This group of genes includes multiple growth factors that are associated with growth and 
development of many tissues and cells. Vascular endothelial growth factors (Vegfa, Vegfab) 
are important factors in increasing vascular permeability and promoting angiogenesis and 
cell migration. The colony stimulating factors (Csf2, Csf3) are cytokines that controls the 
function and differentiation of macrophages and granulocytes. Platelet derived growth factor 
alpha (Pdfgα) is an important mitogenic factor for cells from mesenchymal origin. Epidermal 
growth factor (Egf) is another mitogenic factor that has a potent effect on the differentiation 
of variety of cells from ectodermal and mesodermal origin. Finally the fibroblast growth 
factor family (Fgf) is a family of growth factors that have broad mitogenic and angiogenic 
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activities which play an important role in tissue repair, cell growth, and morphogenesis. 
Figures 3.14 and 3.15 represent bar graph charts of fold difference in mRNA expression of 
these growth factors between the anti-β1/anti-β3 and the control group on both surfaces. 
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Figure 3.14: Bar graph showing the difference in mRNA expression of selective growth 
factors between anti-β1 and control groups on both smooth and rough surfaces. 
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Figure 3.15: Bar graph showing the difference in mRNA expression of selective growth 
factors between anti-β3 and control groups on both smooth and rough surfaces. 
       
     Figure 3.14 shows that when MC3T3-E1 cells were pre-treated with anti-β1 antibody 
prior to plating on smooth surfaces, vegfa, pdgfα, Fgf3, Egf, Csf3 were not regulated with 
less than 2 folds increase or decrease in gene expression. Nevertheless, Vegfb was down 
regulated with over two folds and csf2 on the contrary had over five fold increase in gene 
expression which was statistically significant. However, on rough surface all growth factors 
showed up regulation of gene expression when cells were pre-treated with anti- β1 antibody 
with the exception of pdgfα which was not regulated. The fold increase in gene induction of 
Csf2, and Csf3 was pronounced with over 10 folds increase which was statistically 
significant. Moreover, Fgf3 showed over 4 fold increase in gene induction which was 
statistically significant as well. 
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     Figure 3.15 shows the relative difference in gene induction of the growth factors family 
when MC3T3-E1 cells were pretreated with anti-β3 antibody before plating on both 
experimental surfaces. The key difference in comparison to the anti- β1 group was the 
relative expression of the Vegf family. Vegfa did not show much change on both surfaces 
while Vegfa was down regulated for about two folds on rough surfaces although it was up 
regulated for more that 8 folds in the anti- β1 experiment. Other growth factors showed 
similar trends in gene induction to the anti- β1 experiment, with Fgf3, Egf, Csf2, Csf3 being 
significantly up regulated on rough surface when cells were pretreated with anti- β3 antibody 
before plating.    
3.5.4. Transcriptional factors 
     This group of genes includes some transcription factors that are important for osteoblastic 
differentiation, cell lineage determination, and signal transduction. Twist homolog 1 (Twist1) 
is a transcriptional factor that has been implicated in cell lineage determination and 
differentiation. Smad proteins are signal transducers and transcription modulators that 
mediate multiple signaling pathways. Smad 2 mediates Tgfβ signal and it is associated with 
Smad4 protein which plays an important role in the translocation of Smad2 into the nucleus, 
where it binds to target promoters and forms a transcription repressor complex. Runt related 
transcription factor 2 (Runx2) is essential for osteoblastic differentiation and skeletal 
morphogenesis. It acts as a scaffold for nucleic acids and regulatory factors involved in 
skeletal gene expression. Mutations in this gene are associated with cleidocranial dysplasia 
(130). Finally, Msh homebox1 (Msx1) plays an important role in limb-pattern formation and 
craniofacial development particularly odontogenesis besides it role in embryogenesis. 
Figures 3.16 and 3.17 represent bar graph charts of fold difference in mRNA expression of 
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these transcriptional factors between the anti-β1/anti-β3 and the control group on both 
surfaces. Figure 3.16 and figure 3.17 show that most of the transcriptional factors didn’t 
show dramatic changes in relative gene expression in both experimental conditions. 
Nevertheless, Msx1 levels show statistically significant up regulation of gene expression in 
the anti- β1 experiment on both smooth and rough surface. However, the expression was 
more pronounced on the smooth surface. Moreover, Smad4 gene showed more that two folds 
down regulation on smooth surface in the anti- β1 experiment and Runx2 showed more that 
two folds up regulation on the smooth surface in anti- β1 experiment. All the other 
transcriptional factors in both experiments were not regulated with relative gene induction of 
less than 2 folds. 
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Figure 3.16: Bar graph showing the difference in mRNA expression of selective 
transcriptional factors between anti-β1 and control groups on both smooth and rough 
surfaces. 
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Figure 3.17: Bar graph showing the difference in mRNA expression of selective 
transcriptional factors between anti-β3 and control groups on both smooth and rough 
surfaces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
DISCUSSION 
 
     The success of endosseous implants is determined by the integration of the biomaterial 
substances with the surrounding tissues and the formation of direct bone to implant contact 
(6, 8, 18). The peri-implant bone healing is a complex and synchronized process that 
involves multiple cellular and molecular mechanisms which ends in bone formation and 
wound healing (104). The initial adhesion and spreading of osteoblast-like cells on the 
implant surface is crucial in implementing an appropriate cell response to the surface and is 
related to the skeletal development, homeostasis and maturation of osteoblastic 
phenotype(57, 79, 82, 118).  
     There is growing evidence suggesting that implant surface features affect bone formation 
and related adherent cellular activities (56, 61, 101). Integrin transmembrane receptor has 
emerged as a central regulator of cell biomaterial interactions. Moreover, the ability of the 
osteoblast-like cells to sense and react to different surface characteristics has been attributed 
to the integrin receptors particularly specific heterodimers containing β1 and β 3 integrin 
subunits (63, 71, 108, 122). Nonetheless, the exact role that integrins play in mediating 
osteoblast adhesion to the implant surface and its effect on subsequent cell spreading, 
motility, proliferation, differentiation, and matrix mineralization is not completely 
understood. Thus, this project was conducted to compare and contrast the effects of β1 and 
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β3 integrins on early osteoblast implant interactions and their ability to mediate surface 
specific changes. 
4.1. Experimental model 
     A cell culture model utilizing the mouse osteoblast like MC3T3-E1 cells was used in this 
project. Cell culture models have proved to be a very successful and valuable in investigating 
the aspects of bone formation and osteoblast implant interactions (30, 31, 39). In addition, 
MC3T3-E1 cells are a good model for this project taking into consideration their ability of 
showing different stages of growth and development under cell culture conditions (79). 
Commercially pure grade IV titanium disks were prepared using two different protocols to 
produce surfaces with different roughness topographies (turned or machined versus micro-
rough surface), to investigate the cell behavior on different surface topographies and the 
ability of β1 and β3 integrins to mediate surface specific changes. The AFM surface analysis 
showed that the rough surface has an average surface roughness values that are compatible 
with minimally rough surfaces, which reflects the spectrum of micro-rough implant surfaces. 
Moreover, the Ra values for rough surface were considerably greater than the smooth 
surface. Similar results were documented with Abron and collaborates who used similar 
protocol for surface preparation (4).  
     Functional perturbation of β1 and β3 integrin subunits using integrin-specific monoclonal 
antibodies was used to evaluate the role of these transmembrane receptors in mediating 
osteoblast implant interactions. This procedure has been utilized to identify specific integrin 
subunits and integrin-ligand pairs that mediate osteoblast adhesion to biomaterials and their 
influence on mediating vital cellular mechanisms (82-84, 108, 116). Furthermore, inorder to 
offset any IgG non-specific effects an isotype IgG control was used in the control groups in 
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the same concentration as the monoclonal antibodies.  In a similar experimental protocol, 
Siebers and collaborates examined the influence of integrin subunit-β1 and subunit- β3 on the 
behavior of primary osteoblast-like cells (rat bone marrow cells), cultured on calcium 
phosphate coated and non-coated titanium. They treated the cells with specific monoclonal 
antibodies in a similar fashion to this project. Nevertheless, they didn’t use isotype IgG 
control to match nonspecific IgG effects. Besides, in their experiment they treated the cells 
with antibody concentration of 50μg/ml which is very likely a saturating concentration that 
could possibly have had some inhibitory effect on cell adhesion. Nevertheless, their results 
showed that cell adhesion was only slightly affected by pre-treatment with anti-β3 antibody. 
However, their molecular data showed that pretreatment with either anti-β1 or anti- β3 
resulted in decrease of ALP expression (108).  
     Another important factor in blocking the integrin subunits with specific monoclonal 
antibodies is the timing of the antibody treatment. In our protocol, cells were treated with the 
antibody one hour before the experiment and no serum was added to the cells. Cells, PBS, 
antibody or IgG mixture was incubated in cell culture incubator at 37 °C for one hour before 
the cells were plated on the titanium disks. This protocol, gives the antibody the chance to 
block integrins on all surfaces of the cells. Furthermore, no serum was added to avoid 
competitive binding of the antibodies with serum proteins. Other investigators performed the 
blocking protocol by adding the antibodies to the cell culture medium after the cells were 
initially attached (64, 116, 122). The problem with such protocol is that integrins are also 
expressed on non-binding surfaces of the cells, thus the effect of the antibody will be through 
integrin not involved in cell substrate interaction and this will influence only the cell 
signaling without affecting the cell adhesion as cells had already adhered. Moreover, the 
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initial cell adhesion before the antibody blocking changes integrin expression. Other inherent 
problems with antibody blocking experiments include binding affinities, as well as the 
variable expression levels between the two integrins. More conclusive studies could be 
performed to compare the functions of these two integrins. Examples include, using knock-
out animals or silencing of the integrin subunits. Such studies not only encompass 
transcription, but also, can be complemented by experiments verifying the integrin protein 
expression changes. 
     Three variables than influence initial cell adhesion and spreading (the effect of anti-body 
treatment (β1, β3), surface, and time), were explored using SEM. The numbers of total, 
spread, and round cells were counted in three random areas on each disk. Two disks were 
used for each group at each particular time point. Three calibrated and blinded investigators 
counted the number of cells separately to decrease any risk of bias in the results. SEM 
images at higher magnification were done for subjective evaluation of cell shape, spread and 
interaction with the respective surface. A specific criteria regarding the elongation of the cell 
cytoplasm, the presence of cell processes, as well the diameter of the cell at its longest 
dimension were utilized as guide lines for cell spreading. This method provides the ability to 
evaluate initial cell adhesion as well as spreading both quantatively and qualitatively in the 
same experimental setting. Nevertheless, there are some inherent disadvantages with this 
method including: 
1. Cells with different stages of maturation might present with different sizes and 
shapes. 
2. The differential cell density on different sites of the disks depending on cell plating 
uniformity and accuracy.  
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To overcome these potential problems, semi confluent cells of passage 6 or less were used in 
the experiments and three random areas were selected for each disk. These random areas 
were replicated in each disk to account for plating imperfections. Other investigators 
measured cell number on various substrates when cells were treated with specific monoclonal 
antibodies, or by silencing integrin β1. The cell count was performed by detaching the cells 
using trypsin and counting the cells with a cell counter (108, 122). This method doesn’t 
provide the ability to evaluate cell shape and spread in the same experimental setting. 
Additionally, other methods for evaluation of cell adhesion and spreading had been reported 
in the literature such as; using cell adhesion assays, cell spreading assays, confocal 
microscopic analysis, immunofluoresence assays,  and cell staining. Some of these methods 
were used to evaluate cell adhesion as a function of focal contacts distribution, cytoskeletal 
proteins organization, and staged cell spreading (71, 96). These methods can be very valuable 
in future studies to verify cell adhesion and spreading in a more characteristic fashion 
regarding the organization, distribution of integrin receptors , focal adhesion contacts, and 
cytoskeletal proteins. Furthermore, developing a cell adhesion assay model where mean cell 
surface area can be calculated as a guide line for cell spreading is recommended. This 
method would provide a more objective mechanism for evaluating cell spreading.  
     In order to further investigate the effect β1 and β3 integrin subunits and surface roughness 
on osteogenesis, the relative differences in gene expression of osteogenesis specific genes 
were quantified using the mouse osteogenesis RT²Profiler™ PCR Arrays system. This 
system brings together the quantitative performance of real-time PCR and the multiple gene 
profiling capability of microarrays. This PCR array profiles the expression of a panel of 84 
genes related to osteogenesis. Thus, it provides a unique opportunity to survey these 
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multifunctional genes and investigate the effect of integrin-ligand blocking on multiple 
cellular mechanisms as well as the effect of increased surface roughness on cellular adhesion, 
and osteoblastic differentiation. RT²Profiler™ PCR Arrays system was utilized for a variety 
of molecular biology applications such as; toxicology, oncology, and immunology research 
and proved to be a reliable and accurate tool of analyzing the expression of a focused panel 
of genes(95, 129). 
 
 4.2. Cell adhesion 
     The initial cellular attachment as measured by cell count showed similar number of cells 
on both surfaces in the control group. Nevertheless, numbers of cells were slightly higher on 
rough surface in comparison to the smooth surface and they slightly increase from 4 to 24 
hours as expected.  Although, these differences were not statistically significant, they still 
support the hypothesis that micro- rough surfaces support early cellular adhesion. Moreover, 
by careful observation of SEM images with higher magnification we can clearly see that cells 
on rough surface developed more cellular processes and adopted more irregular elongated 
shape and spanned across the pits on the surface. On the contrary, cells on smooth surface 
were more spherical, flattened, had fewer cellular processes, and seem to be differently 
adhered to the surface (figure 3.9 (A, B)). These observations are consistent with the findings 
of other investigators who found direct correlation between cell attachment and increased 
roughness on the micron-scale level (61, 85). Nevertheless, the literature shows that greater 
cellular adhesion is not necessarily associated with more adherent cell numbers. Keselowsky 
and collaborates found out that α5β1 integrin binding and FAK phosphorylation was directly 
related to surface roughness. Nonetheless, their results also showed that surface roughness 
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was inversely related to adherent cell numbers (64). Similarly, other investigators 
documented the presence of fewer numbers of cells on rough surfaces in comparison to 
smooth titanium surfaces. Kim and collaborates using titanium alloy and MG63 cells, found 
that after 3 days of cell culture proliferation was inhibited by 17% on sandblasted and acid 
etched surface in comparison to smooth surface(65). Wang  and collaborates, using MG63 
cells and grade 2 unalloyed titanium, found after 24 hours in culture, that cell numbers on 
sandblasted and acid etched surfaces and titanium plasma- sprayed (TPS) surfaces were less 
than cell numbers on smooth titanium surfaces and plastic surfaces, which had similar 
number of cells(122). However, in a similar study design Martin and collaborates, found that 
micro- rough surfaces had higher number of cells in comparison to TPS surfaces and similar 
number to smooth surfaces(74). 
     When MC3T3-E1 cells were pre-treated with anti-β1 or anti- β3 monoclonal antibodies, 
the numbers of adherent cells on both smooth and rough surfaces were reduced. 
Nevertheless, the difference was only statistically significant on the rough surface at the 24 
hour time point among the experimental and the control groups. An interesting finding was 
that at the 24- hour time point the difference in cell numbers among the experimental groups 
was higher on smooth surfaces versus rough surfaces with a significant difference in the anti-
β3 group. Moreover, cell numbers in the anti- β3 group were less than the anti- β1 group, 
where cell numbers returned to the control levels on smooth surfaces. These findings may 
suggest that either the cells plated on smooth surfaces had better ability to overcome the 
inhibitory effects of the function-blocking antibodies over time, or that function-blocking 
antibodies had a more pronounced effect on cells plated on rough surfaces. In addition, these 
findings may also suggest that β3 integrins are more active later in the process (24 hours) of 
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cell binding, in comparison to β1 integrin, which might be more active at earlier stages. Our 
results agree with results from other studies. Wang collaborates using MG63 cells found out 
that integrin β1 silencing resulted in 40% decrease in cell numbers after 24 hours on 5 
different surfaces including plastic, polished smooth titanium surface, sandblasted/ acid 
etched titanium surface, and TPS surface. Moreover, their results showed the presence of 
more adherent cells at 24 hours on smooth surfaces versus rough surfaces (122). Keselowsky 
and collaborates reported that cell number on smooth and TPS surfaces were reduced at 3 
days when MG63 cells were pre-treated with anti-α5 antibody to block α5β1 integrin 
function(64). On the otherhand, Siebers and collaborates using rat bone marrow cells found 
out that cell binding was affected differently on calcium phosphate ( CaP) coated surfaces 
versus bare titanium surfaces, when cells were pretreated with anti- β1 and anti- β3 
antibodies. On CaP-coated surfaces, they found that cell numbers decreased around 20-30% 
after pre-treatment with anti- β1. This decrease in cell numbers was significant from 30 
minutes up to 1 day after plating. On the other hand, cell numbers decreased on CaP- coated 
surfaces around 40-50% when cells were pre-treated with anti- β3 antibody. This decrease 
was significant from 30 minutes up to 3 days after plating. Nonetheless, their results on bare 
titanium surfaces did not show significant decrease in cell numbers in the anti- β1 group. But, 
pre-treatment with anti- β3 showed 30% decrease in cell number after 30 and 60 minutes of 
plating on the bare titanium surfaces (108). These results show clearly that cell binding is not 
only integrin dependent but also, surface dependent. Moreover, their results on CaP-coated 
surfaces might suggest that β3 integrin is more important later in the process of cell binding 
(1-3 days) in comparison to β1 integrin. 
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4.3. Cell spreading 
     One of the aims of this investigation was to evaluate the importance of β1 and β3 integrins 
as well as, surface topography in mediating cell spreading. Cell spreading on substrate 
surface, is one of the parameters frequently reported in cell biomaterial interaction research, 
due to its relation to cell migration, growth, and differentiation (13, 124). Nevertheless, cell 
spreading evaluation methods are not standardized. Some investigators used a special soft-
ware to calculate mean cell surface area as an indication of cell spreading (71, 85). On the 
other hand, Lumbikanonda and Sammons developed a model to classify cell attachment/ 
spreading into four stages depending on morphological criteria (70, 96). In the current 
investigation cell spreading was evaluated as a dichotomous variable where cells were 
classified as spread or round depending on specific criteria related to cell morphology and 
dimensions(3). 
     Our results showed that pre-treatment with anti-β1 and anti- β3 antibodies, reduced the 
number of spread cells on both surfaces. This reduction was statistically significant on both 
surfaces at the 2 hour time point and on rough surface at the 24 hour time point. Moreover, 
the results showed that, at the 24 hour time point there were more spread cells on smooth 
surfaces in comparison to rough surfaces in both anti- β1 and anti- β3 groups. This 
observation might indicate that either the cells had better ability to overcome the inhibitory 
effects of function-blocking antibodies on smooth surface, or that surface roughness 
modulates antibody function. Although, our results didn’t show significant difference 
between number of spread cells on rough and smooth surfaces in the control groups, yet they 
are consistent with observations made by other investigators. Several studies reported an 
inverse relationship between cell spreading as measured by mean surface area, and surface 
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roughness as well as cellular adhesion (64, 71, 85). Woodruff  and collaborates, stated that 
cell adhesion is not indicative of how supportive a substrate is to cell spreading which 
doesn’t correlate with focal contact formation(126). On the contrary, Sammons and 
collaborates, reported that rough surfaces of porous microstructure may enhance the rate of 
cell spreading. Nevertheless, their observations were based on morphological criteria rather 
than the mean cell surface area (96). These observations agree with our subjective results 
using highly magnified SEM that showed more morphological variation in cell shape on 
rough surfaces in comparison to smooth surfaces. 
     The mean numbers of round cells in the different experimental groups confirm our 
findings that both integrin β1 and β3 are involved in cell spreading. Furthermore, these 
results show that the anti- β1 group had significantly higher number of round cells in 
comparison to the anti- β3 group on rough surface. These results are consistent with 
observations made by Luthen and collaborates, who reported that β1 integrins are more 
involved in the formation of fibrillar adhesion than β3 integrins, which is affected by the 
surface roughness of titanium (71). 
4.4. Relative expression of osteogenesis genes 
     The effect of β1 and β3 integrin on the relative expression of a panel of osteogenesis 
related genes, was evaluated using RT² Profiler™ PCR Arrays. Several functional group of 
genes related to osteogenesis were examined using this method (appendix A). Nevertheless, 
for simplicity purposes only the results of specific functional groups of genes were presented 
in this thesis and will be discussed accordingly. 
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4.4.1. Bone morphogenic protein superfamily 
     Our results show differential relative expression of Bmp superfamily proteins when cells 
were pre-treated with anti-β1 antibody versus anti-β3 antibody. Pre-treatment of MC3T3-E1 
cells with anti-β1 antibody before cell plating, resulted generally in slight down regulation of 
Bmp superfamily genes on smooth surface. On the contrary when MC3T3-E1 cells were pre-
treated with anti-β3 antibody before cell plating, the Bmp superfamily gene expression were 
slightly up-regulated on smooth surface. Nevertheless, the expressions of Bmp superfamily 
genes on rough surfaces in both experimental groups were similar. They were pronouncedly 
up-regulated particularly Bmp2 and Bmp6. This differential expression might suggest that 
the effect of the surface on Bmp superfamily gene expression is beyond the effect of β1 and 
β3 integrins. Moreover, it might suggest that the cells respond to integrin blocking by 
compensatory effect through other integrin and non-integrin signals. Another explanation of 
this finding could be that the antibody it self creates signals that is reflected in up regulation 
of Bmp superfamily gene expression. Nonetheless, these results still show that both β1 and 
β3 integrins might be involved in mediating surface specific changes, which is evident in the 
differential expression of Bmp superfamily proteins on rough versus smooth surfaces. 
     These results agree with observations from previous studies which show that Tgfβ 
superfamily and Bmps particularly Bmp2 are correlated and work closely in mediating cell 
adhesion. Nissinen and collaborates showed that human recombinant Bmp2, regulate cell 
matrix interactions by modifying the expression of integrin α3β1 that mediates cell adhesion 
to laminin-5(86). On the other hand, Shah and collaborates reported that  pre-treatment of 
primary human osteoblastic cells with Bmp-2 for 12 hours before plating on titanium alloy, 
resulted in increased expression of α5 and β1 integrin subunits, fibronectin, and focal 
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adhesion kinase expressions. In addition, they showed that this increased expression was 
associated with stimulated cell adhesion and proliferation of osteoblastic cells, which was 
reflected on long term mineralization (105). Similarly, Lai and Su documented that Bmp2 
up-regulates the expression of αvβ integrins which in turn, play a critical role in Bmp2 
osteoblastic function (66). 
 
4.4.2. Bone matrix proteins 
     For this group of genes the results were similar when the cells were pre-treated with anti- 
β1 or anti- β3 antibodies particularly for ALP and Sost genes. On smooth surface there was 
slight down-regulation of ALP and slight up-regulation of Sost. However, there was a 
significant up-regulation of both genes expression on rough surface. An interesting 
observation was the up-regulation of Sost gene expression, when cells were pre-treated with 
either anti- β1 or anti- β3 antibodies. This gene is a Bmp antagonist, and it is associated with 
reduction of the expression of proteins associated with osteoblastic differentiation, 
proliferation, and matrix mineralization (125). These results may indicate that β1 and β3 
integrins are involved in mediating osteoblastic differentiation in a surface dependent 
manner.  
     The ALP relative gene expression was surface dependent with slight down- regulation on 
smooth surfaces and significant up-regulation on rough surfaces. These observations agree 
and disagree with observations made by other investigators in similar study designs. Wang 
and collaborates reported that blocking β1 integrin function with specific antibody, resulted 
in reduction of ALP expression in Mg63 cells. Moreover they observed that this decrease in 
gene expression was dependent on time of antibody treatment, dose of antibody, and 
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substrate on which the cells were plated (122). Similarly, Siebers and collaborates reported 
that pre-treatment of rat bone marrow cells with either anti- β1 or anti- β3 antibodies before 
plating, resulted in surface dependent decrease in ALP gene expression(108). Although, it is 
difficult to compare these contradictory results, due to differences in cell types, substrates, 
and experimental conditions, yet, they all agree that blocking β1 and β3 integrin function 
resulted in substrate dependent change in ALP gene expression.   
 
4.4.3. Growth factors 
     The relative gene expressions of several growth factors were evaluated. The results were 
similar in both the anti- β1 and anti- β3 groups with the exception of the vascular endothelial 
growth factors. These results further confirm the observation that blocking β1 and β3 
function with specific monoclonal antibodies resulted in surface dependent change in growth 
factors gene expression. These results are similar to observations made with other functional 
group of genes and the same explanations may be applied. Nevertheless, the differential 
expression of the Vegf genes, particularly Vegfa among the anti- β1 and anti- β3 
experimental groups was of interest. In the anti- β1 group, Vegfa was slightly down regulated 
on smooth surface and up regulated on rough surface. Nevertheless, in the anti- β3 group it 
was down regulated on both surfaces with more down regulation on the rough surface. It is 
well documented that integrins β1, β3, and β5 are expressed in endothelial cells and are 
involved in the process of angiogenesis through their effect on Vegf (12, 72). Nevertheless, 
integrin β3 particularly αvβ3 has the most potent effect on angiogenesis. Mahabeleshwar and 
collaborates showed that inhibition of β1, β3, and β5 integrin expression in endothelial cells 
resulted in down regulation of endothelial cell adhesion and migration. Moreover, they 
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reported that inhibition of β3 integrin resulted in the most potent reduction in capillary 
growth stimulated by Vegf. Our results agree with these observations reported in relation to 
endothelial cells. Further investigation of the correlated effect of integrins particularly β3 and 
Vegf in osteoblasts is of interest, since angiogenesis is a crucial process in peri-implant bone 
healing. 
 
4.4.4. Transcriptional factors 
     The results in this group of genes surprisingly did not show much difference in the 
relative expression among the different experimental groups on both surfaces, with the 
exception of Msx1 gene in the anti- β1 group. Nevertheless, an interesting finding was that 
the Smad proteins were down regulated in the anti- β1 group for more that two folds on 
smooth surface. This correlates with the fact that these proteins works as signaling 
molecules, and are part of the down stream signaling mechanism of Tgfβ and Bmps(45). This 
might further indicate the involvement of β1 integrin in modulating osteoblastic 
differentiation. The other interesting observation was the significant up-regulation of Msx1 
gene expression when cell were pre-treated with anti-β1 antibodies particularly on smooth 
surface. There is no known connection between this gene and integrins. This observation 
might suggest that the effect of the surface is complex and goes beyond the integrin 
transmembrane receptor. Moreover, there is a possibility that the blocking antibody, might 
un-mask key non-integrin signals. Nevertheless, it is interesting to further explore the 
possibility of having a correlation between β1 integrin function and Msx1 gene expression in 
osteoblasts.  
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4.5. Summary of findings and future recommendations 
          The findings of this in-vitro study can be summarized as following: 
1. Both β1 and β3 integrins are involved in mediating osteoblast implant surface 
interactions. They have a direct effect on initial cell adhesion and spreading in a 
surface and time dependant manner. 
2. Integrin β1 and β3 seem to be active at different stages of cell adhesion, with β1 being 
more active early in the process in comparison to β3 which has more potent effect 
later in the process. 
3. Function blocking of both integrin subunits resulted in variable and surface dependant 
differences in gene expression of multiple genes related to osteogenesis. 
Nevertheless, function blocking antibodies seem to initiate signals that translate in up-
regulation of multiple genes. 
4. The molecular results might suggest that, cell biomaterial interaction is a complex 
process, which can be further mediated by other integrin and non-integrin molecules. 
5. It seems like osteoblast like cells have the ability to compensate to a great extent for 
the blocking strategy applied in this investigation. 
6. More conclusive comparative studies are recommended. These studies should be 
performed at different time points, and involve innovative techniques to knock out the 
integrin subunits such as; knock- out animals or RNA silencing (siRNA). Such 
designs can result in more precise evaluation of the effect of integrin receptors on cell 
biomaterial interaction and provide better insight on the long term effect of these 
interactions.  
  
 
 
 
 
 
CHAPTER 5 
CONCLUSIONS 
 
     Within the limitations of this in-vitro investigation we can make the following 
conclusions: 
1. Blocking integrin-β1 and integrin- β3 subunits with antibodies has an inhibitory effect 
on osteoblast like cell binding, and spreading to commercially pure titanium surfaces in 
vitro. 
2. Beta one and beta three integrin mediation of initial cell adhesion and spreading is both 
time and surface dependent. 
3. Both beta one and beta three integrins are involved in mediating surface specific 
changes, that modulate osteogenesis related gene expression. However, other integrin and 
non-integrin molecules might be involved in this process. 
4. Function-blocking antibodies (that block cell binding) may activate signaling which 
result in a substrate dependent temporal expression of osteogenesis related genes. 
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APPENDIX A 
Functional Gene Grouping 
 
1. Skeletal Development: 
Bone Mineralization: Ahsg, Ambn, Enam, Fgfr2, Smad1, Tuft1. 
Cartilage Condensation: Bmpr1b, Col11a1, Col2a1, Sox9. 
Ossification: Ahsg, Ambn, Dmp1, Enam, Phex, Sost, Tfip11, Tuft1. 
Osteoclast Differentiation: Tnf. 
Other Skeletal Development Genes: Bmp2, Bmp4, Bmp5, Bmp6, Runx2, Tgfb1, Vdr. 
2. Bone Mineral Metabolism: 
Calcium Ion Binding and Homeostasis: Anxa5, Bmp1, Cdh11, Comp, Egf, Mmp2, Mmp8, 
Vdr. 
Phosphate Transport: Bmp5, Col10a1, Col11a1, Col12a1, Col14a1, Col1a1, Col1a2, 
Col2a1, Col3a1, Col4a1, Col4a2, Col5a1, Col6a1, Col6a2, Col7a1. 
3. Cell Growth and Differentiation: 
Regulation of Cell Cycle: Fgf1, Fgf2, Fgf3, Itgb1, Pdgfa, Tgfb1, Tgfb2, Tgfb3, Vegfa, 
Vegfb. 
Cell Proliferation: Fgf1, Fgf2, Fgf3, Fgfr2, Pdgfa, Smad3, Tgfb1, Tgfb2, Tgfb3, Tgfbr2, 
Vegfa, Vegfb. 
Growth Factors and Receptors: Bmp1, Bmp2, Bmp3, Bmp4, Bmp5, Bmp6, Bmpr1a, 
Bmpr1b, Csf2, Csf3, Egf, Fgf1, Fgf2, Fgf3, Fgfr1, Flt1, Gdf10, Igf1, Igf1r, Pdgfa, Scarb1, 
Tgfb1, Tgfb2, Tgfb3, Tgfbr1, Tgfbr2, Tgfbr3, Vdr, Vegfa, Vegfb. 
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Cell Differentiation: Bmp2, Bmp4, Bmp6, Csf2, Fgf2, Igf1, Runx2, Smad2, Sox9, Tfip11, 
Tgfbr2, Twist1. 
4. Extracellular Matrix (ECM) Proteins: 
Basement Membrane Constituents: Col4a1, Col4a2. 
Collagens: Col11a1, Col1a1, Col1a2, Col2a1, Col3a1, Col4a1, Col4a2, Col5a1, Col6a1, 
Col6a2. 
ECM Protease Inhibitors: Ahsg, Col7a1, Serpinh1. 
ECM Proteases: Bmp1, Ctsk, Mmp10, Mmp2, Mmp8, Mmp9, Phex. 
Structural Constituents of Tooth Enamel: Ambn, Enam, Tuft1. 
Other ECM Molecules: Akp2, Bgn, Bmp2, Bmp4, Bmp5, Bmp6, Bmpr1a, Col10a1, 
Col12a1, Col14a1, Comp, Csf2, Csf3, Dmp1, Egf, Fgf2, Fgf3, Fgfr1, Fgfr2, Fgfr3, Flt1, 
Fn1, Gdf10, Igf1, Igf1r, Itga2, Itga2b, Itgam, Itgb1, Pdgfa, Sost, Tfip11, Tgfb1, Tgfb2, 
Tgfb3, Tgfbr1, Tgfbr3, Vcam1, Vegfa, Vegfb. 
5. Cell Adhesion Molecules: 
Cell-cell Adhesion: Cdh11, Icam1, Vcam1. 
Cell-matrix Adhesion: Itga2, Itga2b, Itga3, Itgam, Itgav, Itgb1. 
Other Cell Adhesion Molecules: Cd36, Col11a1, Col12a1, Col14a1, Col5a1, Col6a1, 
Col6a2, Comp, Fn1, Scarb1. 
6. Transcription Factors and Regulators:  
Msx1, Nfkb1, Runx2, Smad1, Smad2, Smad3, Smad4, Sox9, Twist1, Vdr.  
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